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Cellular model systems are essential platforms used across multiple research fields for 
exploring the fundaments of biology and biochemistry. By multicompartmentalization, systems 
can be created where nanocompartments (serving as artficial organelles) are encapsulated in 
microscale compartments (serving as the cellular structure).  
The first topic of this thesis focusses on polymersomes that are supplemented with membrane 
proteins and enzymes. The biomolecules endow such bioactive vesicles with specific cellular 
functions and enable diverse applications in nano- or pharmatechnology. In this work, we 
particularly introduce a new strategy for modifying the membrane proteins via chemical-
oriented approach. Until now, significant progress in functionalization of polymersomes has 
been obtained by embedding modified proteins into the membrane for stimuli-responsive 
permeability. Inside the polymersomes, enzymes are encapsulated and catalyze distinct 
reactions with molecules diffusing through the membrane. Due to the resulting triggerable 
activity, such bioinspired vesicles are able to detect diverse environmental signals and show a 
remarkable potential for diverse applications such as biosensing and triggerable drug release. 
We introduce a small, periodate-sensitive designed linker blocking the passage through a 
protein channel (OmpF) reconstituted into the membrane of polymersomes. By combining tools 
of organic and bioconjugation crosslinkers, we synthetized this organic linker. OmpF was 
successfully modified with the linker and led to a stimuli-responsive permeability of the 
vesicles. In presence of periodate, the linker was cleaved and allowed substrates to diffuse 
inside the compartments where encapsulated laccase catalyzed the reaction to the respective 
radicals with a characteristic absorbance that was detected. Additionally, the labelling of OmpF 
with the stimuli-responsive linker is performed under mild conditions (no organic solvents, 
room temperature, pH 7) and therefore it has the potential to be adapted for diverse proteins 
that are more sensitive than OmpF. 
With regard to the microscale compartments, synthetic Giant Unilamellar Vesicles (GUVs) and 
Giant Plasma Membrane Vesicles (GPMVs) are one of the most prominent cell-like 
compartments. GUVs are formed by self-assembled lipids or polymers while GPMVs, are 
directly derived from cells. The second project presented here, focusses on GPMVs as a 
platform of cell-like compartments. GPMVs include most of the cellular components and thus, 
provide the highest similarity to real cells. GPMVs will facilitate the investigation and the 
understanding of different behaviors and characteristics of cellular processes. Our aim is to 
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promote the further development of GPMVs with regard to the study of nanoparticles (NPs) 
under physiological conditions. We studied molecular factors that determine the successful 
transfer of cellularly taken-up NPs transferred into formed GPMVs. In particular, we 
investigated the impact of size, concentration and surface charge of NPs in correlation with 
three different cell lines: HepG2, HeLa, and Caco-2. We observed that polystyrene (PS) 
carboxylated NPs with a size of 40 nm and 100 nm were successfully and efficiently transferred 
to GPMVs derived from all cell lines. Then, we investigated the distribution of NPs inside 
formed GPMVs and established the average number of NPs/GPMVs and the percentage of all 





FUNCTIONAL BIOINSPIRED COMPARTMENTS 
 
The first chapter provides an introduction of the fundaments of bioinspired compartment 
attracting high scientific interest. Considering the inspiration by real cell membranes, the 
membrane structure of synthetic compartments composed of amphiphilic lipids and polymers 
is explained (both nano- and microscale compartments). Polymersomes, as prominent and 
frequently applied 3D nanostructures formed by self-assembly, are introduced more in detail; 
the focus is on polymersomes including different biomolecules for controllable 
multifunctionality (membrane proteins and enzymes). Such nanocompartments show high 
potential for various applications where the most famous of which are introduced in this 
chapter. In the second part, the reader is given an overview of cell-like compartments with the 
focus on microscale compartments synthetically produced (GUVs) or directly derived from 
cells (GPMVs). Regarding cell-like platforms, GPMVs are presented as promising candidates 
and are described in detail, since GPMVs are studied for further development in the later 









Membrane structure of synthetic nano- and microscale 
compartments 
 
For many different scientifical domains, the design and development of synthetic compartments 
in the nano- and microscale are of big advantage as they have versatile bioinspired 
functionalities due to resemblance to real cells and their organelles. One challenge is the mimic 
of the cellular membrane built up in vitro with laboratory equipment. Lots of different 
parameters and impact factors have to be taken into account and put into practice, such as the 
intrinsic mechanical properties, membrane composition (lipid, polymer) and orientation.1-7  
 
Inspiration by biomembranes  
The synthetic membrane presents the fundamental structure of bioactive nanocompartments 
and cell-like compartments. The in-depth and comprehensive investigation of native cellular 
membrane architectures, advanced significantly the development of synthetic artificial 
membrane assemblies. The cell is surrounded by the membrane protecting selectively the 
cellular interior from the external environment. The biomembrane, also called plasma 
membrane, is mainly built up of dynamic phospholipid bilayers. Phospholipids are polar, 
amphiphilic molecules including a hydrophilic zwitterionic phosphate head group and two 
(un)saturated hydrocarbon chains as hydrophobic tails.8 In an aqueous milieu as it is in animal 
and human bodies, phospholipids are assembled in 2D double layers (bilayer), where the 
hydrophilic head groups are oriented to the water interfaces due to cohesive, attractive forces. 
The high stability and also high flexibility of the membrane is the results of a very important 
and complex balance of the components.  
Straight lined saturated fatty acids incorporated as the hydrophobic tails leads to a denser, stable 
structure. Unsaturated chains (unsaturated fatty acid) show a kink in the area of the C=C double 
bond and result in more lose packing of the phospholipids in the membrane supporting the 
flexibility. Regarding the fluidity of phospholipids in general, rigid compounds or steroids like 
cholesterol, have to be incorporated to allow a stable solidified structure. Their amount has to 
be balanced. Too many rigid components lead to a lack in flexibility and the resulting stiff 
membrane breaks. On the other hand, a lack of steroids in the membrane causes damage as the 
membrane lost stability.9 
The main purpose of the cell membrane is the separation of the intra- and extracellular 
environments. In particular, the membrane is a passive partition wall for cells. The diffusion 
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processes though the membrane into the cell (uptake) or to the exterior (excretion) are 
controlled by the phospholipid bilayer. However, the active cell transport is achieved by diverse 
additional embedded membrane proteins allowing selective permeability towards molecules 
and ions. In the cell membrane are lots of different membrane proteins fulfilling particular tasks 
essential for pH regulation, the metabolism, the cell signaling/communication and adhesion.1, 
10, 11 The OmpF membrane protein (Outer membrane protein F), for example, occurs in bacterial 
membranes as a simple non-specific protein channel. It is shaped as beta barrel with a diameter 
of around 30 Å enabling the diffusion of molecules with a size of approximately 600 Da in both 
directions (in and out of the cell). The rather non-charged inner structure of OmpF further 
supports the transport of charged and uncharged compounds. Another advantage of OmpF is 
its stability towards several conditions like temperature, or solvents. In contrast to most 
membrane proteins, OmpF is easy to isolate from bacteria while maintaining the structure and 
functionality. The robust OmpF can further be engineered, biologically and chemically, which 
turns OmpF and mutants to frequently used tools for permeabilizing the polymeric membrane 
of synthetic bioactive vesicles.12-15 
Besides that, most membrane proteins are difficult to isolate and reconstitute. The highly 
complex structure and dynamics of the cell membrane itself, where phospholipids and 
membrane proteins diffuse freely within, presents a very big challenge for mimicking the 
biomembrane with laboratory equipment. As first approach for membrane mimics, the 
components for a synthetic membrane are narrowed down in order to provide a controlled self-
assembly with fundamental functions.  
 
Synthetic membranes based on lipids and polymers 
Lipid-based synthetic membranes  
Synthetic membranes imitating the plasma membrane with a close composition, are assembled 
by lipids, or rather natural occurring phospholipids. This approach seems to be consequential 
due to the fact that phospholipids are plentifully present in biomembranes. In addition to that, 
the lipids are well-characterized and facile to purchase in a huge variety. They include basically 
4 components: i) glycerol or sphingosine serving as basic structure, ii) a phosphate for the 
hydrophilic head group, iii) an alcohol, usually containing a primary/tertiary amine in addition 
(the alcohol binds to the phosphate, the amine determines the charge of the head group), and 
iv) 2 fatty acids as hydrophobic tails.16 The fatty acids are available in many variations 
(saturated, unsaturated, number of carbons). The resulting 3D self-assemblies depend on the 
molecular conformation of the fatty acids. There are different structures, like micelles and 
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vesicles, that are naturally formed by phospholipids in aqueous solutions (Figure 1). The 
molecular structure and stability of lipidic self-assemblies is controlled by several parameters 
of the phospholipids, such as ionic strength, size of the heap group and saturation of the fatty 
acids. Additionally, external conditions such as pH, ion concentrations and temperature have 
an impact on the assembly.16-18  
 
 
Figure 1. Phospholipids and their self-assemblies – a) Scheme of the structure and charge 
distribution of a typical phosphoglyceride. On the left is the polar phosphoric group esterified 
to the hydroxyl group of an alcohol. On the right is the apolar aliphatic chains esterified to the 
central moiety, which is a glycerol. b) Assembly of a lipidic bilayer. The longer apolar chains 
are stacked in the internal department of the bilayer. c) Architecture of liposomes and micelles. 
The representative steric organization of a liposome (left) and a micelle (right). Liposomes 
have a lipidic bilayer (bottom) whereas micelles are constructed only by one lipid layer that 
has its apolar section turned inwards while its polar heads interact with the environment. 
Adapted from Bitounis with permission.18 
Lipidic vesicles, also called liposomes contain a lipid bilayer forming the membrane. The 
molecular structure of the bilayer is often formed by a mixture of bilayer-preferring lipids, like 
phosphatidylserine (PS), making up merely 20-50%. The majority is non-bilayer preferring 
lipids, such as the unsaturated phosphatidylethanolamine (PE), that have to be included 





The basic structure of natural plasma membrane could be mimicked with labatory equipment 
as the membrane mainly consists of 6 components: PS, PE, phosphatidylinositol (PI), 
phosphatidylcholine (PC), sphingomyeline (SM) and steroids (i.e. cholesterol). The difficult 
task of closer mimicking the plasma membrane is the reconstitution of the diverse membrane 
proteins.1, 19 Membrane proteins are mostly very fragile building blocks. The isolation and 
purification of such sensitive and proteins while retaining their functionality, represent the first 
challenge. Second, the membrane proteins as amphiphilic biomolecules have to be suspended 
in aqueous solutions containing detergents, that disturb the self-assembly of the membrane. Due 
to this, the synthetic lipid membranes have a lack of natural permeability and stability. 
However, phospholipids allow close mimics of the cell membrane. Until today, lipid-based 
synthetic membranes have given new insights into many different important parameters 
considering i) lipid and protein distribution20, ii) activity and function21, 22, iii) the geometric 
flexions in the membrane (affected by protein binding) and iv) the protein-induced membrane 
deformation established in trafficking.23 
 
Polymer-based synthetic membranes  
Besides amphiphilic lipids, amphiphilic block copolymers are classic components for building 
cell-like membrane structures. In contrast to lipids, synthetic polymers form a more stable and 
robust membrane that allows different chemical modifications for designable properties 
(Figure 2).24-26 Until today, there is a huge selection of polymers synthesized in laboratories, 
giving access to diverse self-assembled structures.  
Usually, the polymers are grouped in homo- and copolymers and polyelectrolytes. 
Homopolymers consists of repetitive monomers connected by covalent bonds.27 The monomers 
are units of relatively low molecular weight. (Block) copolymers are composed of at least two 
different blocks of covalently attached homopolymers. In order to obtain homo- and 
copolymers with well-defined properties and low poly dispersity, synthetic strategies such as 
living ionic polymerization, controlled/quasi- ‘living’ radical polymerization (CRP), and (ring-
opening polymerization (ROP) have been developed.28-32 
Polyelectrolytes present an individual group of polymers that assemble to polyelectrolyte 
multilayer (PEM) films. These films are formed by positively and negatively charged 
polyelectrolytes that are alternatively adsorbed onto a template. However, polyelectrolytes are 
beyond the scope of this thesis.33-35  
The amphiphilic character of synthetic copolymers (containing both lipophilic and hydrophilic 
groups) is fundamental for forming a polymeric membrane. The final polymer chain is 
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composed of several hydrophilic and hydrophobic homopolymeric blocks in different ratios. 
The resulting self-assembled membrane architectures (spherical, cylindrical, gyroidal, lamellar) 
depend on the ratio, as well as on other properties of the copolymer such as length, 
polydispersity and mass.36-38 This thesis focusses especially on water-enclosing spherical 
polymeric nanostructures, so called polymersomes.  
 
 
Figure 2. Schematic representation of liposomes and polymersomes –  Polymersomes (right) 
are synthetic analogues of liposomes (left) and are constituted of amphiphilic block copolymer 
membrane. Whilst most properties are similar for both carriers, polymersomes exhibit a high 
versatility and an enhanced stability. Adapted from Messager with permission.24 
 
The chemical composition of the copolymers has an essential impact on the resulting synthetic 
membrane and its functionality. The most common amphiphilic block copolymers used for self-
assembled membranes include hydrophilic blocks such as poly(acrylic acid) (PAA), 
poly(ethylene oxide) (PEO), poly(ethylene glycol) (PEG), or poly(2-methyl-2-oxazoline) 
(PMOXA), mixed with a hydrophobic block, such as polystyrene (poly(1-phenylene-1,2-diyl), 





Structures of 3D nanocompartments self-assembled by lipids and polymers 
Synthetic nanocompartments are built up by the “bottom up” approach where lipids and 
polymers self-assemble to distinct structures.36-38, 42 The most common self-assembled 3D 
structures at the nanoscale are nanoparticles, micelles and vesicles.16, 43-46 All the spherical 
architectures are available in colloidal suspensions containing aqueous or organic solvents. The 
resulting structure depends on thermodynamic parameters during the formation. There are also 
2D architectures based on identical components (planar membranes), but this strategy is beyond 
the scope of this thesis and is discussed detailed elsewhere.47-49   
Micelles are colloidal aggregates made by macromolecules, rather smaller amphiphilic lipids 
and polymers. The orientation of the molecules depends on the medium they are suspended in. 
In contrast to inorganic nanoparticles (i.e. gold, carbonates, or iron oxide), lipid and polymer 
based nanoparticles have a more deformable, but less stable structure. If the lipid/polymer 
concentration is higher than the critical micellar concentration (CMC), micelles self-assemble. 
The amount of forming micelles depends on the chain length of the macromolecules, on the 
different interactions between the solution and on the chemical structure of the amphiphilic 
macromolecules (van-der-Waals, hydrogen bridge bonds).25, 50 
A neat distinction between micelles and nanoparticles is not always possible and there are 
different definitions for both systems. Commonly, the term “micelles” is used for dynamic 
systems while “nanoparticles“ are used for kinetically trapped systems. Here, the typical 
challenge is that the existing exchange dynamics can often not be investigated and that it is just 
not known whether the system is dynamic or frozen.51, 52  
The most considerable difference between the 3D structures of nanocompartments is found by 
comparing nanoparticles and micelles with vesicles. Micelles/nanoparticles have a solid core. 
Due to steric hindrance of lipidic and polymeric chains inside the core, infiltrated bioactive 
components are inactive until their release. The vesicle architecture, by contrast, shows a lipidic 
or polymeric membrane forming a defined inner cavity (Figure 3). Vesicular structures of sizes 
up to 1 µm self-assembled from amphiphilic phospholipids or polymers, are termed liposomes 
or polymersomes.23 The resulting hollow sphere allows the entrapment of diverse active 
biomolecules staying intact. The rather robust membrane of vesicles, especially a polymeric 
membrane, protects encapsulated cargos from external environment and prevents degradation 
of sensitive biological elements. On the other hand, vesicles with a lipidic membrane relate 
more to real cells and their organelles which supports the biocompatibility.  
Depending on the favored applications, each different structure of 3D nanocompartments can 
be of advantage. In the following part, three very famous and dominant applications of bioactive 
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Figure 3. Liposomes and polymersomes – Architecture of lipidic and polyermic vesicles 
presented as cross section and 3D image. Adapted from Rideau with permission.25  
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Self-assembled bioactive polymersomes 
 
Living cells and their metabolism represent a complex system were various biochemical 
reactions take place simultaneously without reducing efficiency, and specificity. Bioactive 
nanocompartments are synthetic structures at the nanoscale mimicking these highly organized 
cellular processes and pathways. These compartments are a very promising tool in different 
research fields such as medicine, catalysis, and biotechnology. For developing biohybrid 
systems, nano-sized vesicles, especially polymersomes, are preferred over micro-sized 
polymeric vesicles, like giant unilammelar vesicles (GUVs). Compared to GUVs, 
polymersomes show a higher stability due to the enhanced surface tension caused by the smaller 
size. Furthermore, there is an increasing progress in the reconstitution of membrane proteins in 
polymersomes while such procedures have to be often optimized for GUVs.  
Bioactive polymersomes show great results in therapeutics and are applied in various kinds of 
sensing systems for diagnostics and environmental science. These hybrid structures help to 
advance our understanding of engineering smart nanomaterials and allow additional insights 
into biological basic processes. 
 
 
Figure 4. Schematic representation of bioinspired polymersomes –  Conceptual overview of 
bioinspired polymersomes and polymer membranes highlighting some possible applications of 
such assemblies. Adapted from Palivan with permission.53 
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The polymersomes are built up by the “bottom up” approach where polymers self-assemble to 
distinct structures. Depending on the polymer, different formation techniques have to be applied 
for forming nanoscale vesicular structures. The conventional techniques are the thin-film 
rehydration method54-56 and solvent exchange method.57 
With such “bottom up” techniques it is possible to combine the preparation of synthetic 
compartments with bioactive molecules and units. Lots of different membrane proteins have 
already been reconstituted in the synthetic membrane of polymersomes. Additionally, active 
biocompounds like enzymes, have been incorporated for developing polymersomes with 
engineered controllable functionalities (bioactive nanocompartments) valued for many diverse 
applications (Figure 4). 
 
Architectures of bioactive polymersomes 
Polymersomes are nanoscale vesicles self-assembled by amphiphilic block copolymers 
representing the analogues to liposomes. In aqueous media the hydrophilic block of a diblock 
exposes to the surface, while the hydrophobic block form the inner part of the membrane. 
However, depending on the copolymer, the membranes will have a different morphologies. In 
the resulting membrane, the polymers are commonly aligned as as bilayers in case of diblocks 
(AB). Symmetric triblock copolymers (ABA) have to possible conformations: the hydrophobic 
block can either form a loop so as the hydrophilic chains are on the same side of the membrane 
(U-shape) or they can stretch forming a monolayer with the two hydrophilic blocks at the 
opposite sides of the membrane (I-shape). ABC triblock copolymers assemble into asymmetric 
membranes where the internal and external surface chemistry differ from each other in the 
resulting polymersomes.58, 59 The orientation of the hydrophilic block polymers depends 
additionally on more parameters such as steric hindrance and polymerblock lengths. Bigger and 
more bulky blocks form the outer surface of the polymersomes.60, 61  
The thickness of polymeric membranes ranges from 5-30 nm, depending on the polymer chain 
length.59 The size of the polymersomes is often affected by the polymersome formation method 
which has to be selected accordingly for different polymers. In order to obtain high 
monodispersity and a decreased size distribution, the polymersomes are usually extruded with 
filters having defined pore sizes. In order to form vesicles by self-assembly, determining 
parameters have to be taken into account carefully: i) the packing parameter (p = v/a0lc = 0.5 -
1), ii) the hydrophilic to whole mass balance in a range of 25 - 45% (f-value), and iii) the 
polydispersity index (PDI) of approximately 1 of the amphiphilic block-copolymer (v = volume 
of hydrophobic part, a0 = contact area of head group, lc = length of hydrophobic part).36-38, 62-65  
 16 
With regard to the robust and thicker membrane of polymersomes, different strategies have 
been investigated in order to increase and control the permeability while the polymeric 
structures stay intact for extended periods of time.59 Depending on their chemical nature, homo- 
and copolymers are able to form polymersomes with intrinsic stimuli-responsive properties, 
especially pH-responsiveness. For example, polymersomes self-assembled by copolymers with 
tertiary, protonable amine groups show reversible swelling properties (breathing membrane) at 
distinct pH-values. Such pH-sensitive copolymers can include a PDEAEMA (poly(2-
(diethylamino)ethyl methacrylate)), PDMAEMA (poly(2-(dimethylamino)ethyl methacrylate), 
or PAD (poly(N-amidiono)docecyl acrylamide)) as protonable block.66-68 Further polymers 
forming pH-responsive polymersomes are PAA69, 70 and PSS (poly(styrene sulfonate)).71 
Additionally thermoresponsive polymersomes based on PNIPAM (poly(N-
isoproylacrylamide)) have been successfully developed where the thermosensitive PNIPAM 
forms hydrogels in situ when the temperature is raised above the lower critical solution 
temperature.72 
Another strategy for developing permeable poylmersomes describes stable, non-responsive 
vesicles, where the spontaneous formation of a porous membrane is effected by organic 
solvents or particular stimuli-responsive biomolecules. In contrast to organic solvents, 
biomolecules achieve a triggerable  and thus, a more controllable permeability and present the 
focus of this chapter. A promising approach to allow a more controlled and selective 
permeabilization of the vesicles for protons, ions or small molecules is achieved by 
reconstituted membrane proteins and biopores. Up to now, lots of different membrane proteins 
have been successfully inserted; among them i) channels and pores (Outer membrane protein 
F; OmpF12, 14, 73-75 , Aquaoporin; Aqp076, FhuA (ferric-siderophore transporter)77, maltose pore 
protein; LamB78,  ii) transporters of ions and electrons (a-Hemolysin; aHL, ionomycin for 
divalent cations), and iii) channel forming peptides, like melittin and gramicidin (gA).79, 80  
Additonally, mutants of OmpF, especially, present an elegant strategy to develop stimuli-
responsive permeability. Even though the engineering and expression of OmpF mutants require 
complex procedures, the resulting advantages overcome this issue. For example, a pH 
dependent diffusion efficiency through OmpF 6His mutant was observed where the histidine 
substitutions strongly influences the local electrostatic field, the channel diameter and the 
constriction zone. The total charge states of histideines resulted in a pH-dependent release when 
reconstituted in nanocompartments.81 Second, OmpF mutants have been used to allow a 
selective modification of the proteins resulting in a stimuli-responsive opening/closing of the 
pores in polymersomes presenting the focus of the following chapter.12, 15 Due to this, such 
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biohybrid nanosystems are a very promising tool for different technologies in the fields of 
bioengineering and biomedicine.82  
For a successful reconstitution of membrane proteins, it is essential to choose the appropriate 
polymer that supports the correct orientation of the protein while preserving the natural 
functionality. A functional reconstitution requires polymers forming a flexible enough 
membrane. The polymers have to conform to the lager hydrophobic parts of the protein by 
coiling.53, 59, 82 Especially larger proteins (3.3-7.1 nm) induce imbalance in hydrophobic 
interactions with the block copolymers (9-13 nm) and hamper the functionality of the protein. 
A sufficient flexibilty of the copolymer allows the reconstitution of membrane proteins 
although the resulting synthetic membrane is thicker than the protein itsself. Moreover, the 
polydispersity of the copolymer might also be an essential requirement as smaller polymer 
chains arrange around protein while longer chains form the stable membrane of the 
polymersomes to allow a successful insertion.83 Moreover, a membrane self-assembled by ABC 
block copolymers allows a specific orientation of the membrane protein due to the different 
hydrophilic parts.84 Triblock copolymers composed of PMOXA-b-PDMS-b-PMOXA are also 
great candidates for the insertion of proteins in synthetic membranes as they combine all 
fundamental requirements and present the focus of this part. The PDMS block offers suitable 
flexibility and fluidity to entangle the protein  while providing the stability of the membrane.83 
With regard to the membrane proteins inserted in polymersomes, mild conditions including 
temperature, pH, aqueous medium, are essential for a successful reconstitution as membrane 
proteins are often very fragile and easily denaturate outside the cellular membrane. Therefore, 
For the orientation-specific reconstitution of different membrane proteins into polymersomes, 
diverse worked-out strategies are necessary. One strategy is the particularized membrane 
destabilization of the vesicles by detergents before adding the protein or the incorporation 
during the self-assembly process (post-hoc insertion). The operation process has to be often 
optimized for each membrane protein, but the general key step of all methods is the removal of 
the detergents the proteins are usually resuspended.83 
 
Polymersomes with modified membrane proteins and channels 
Remarkable progress in functionalized polymersomes has been obtain by reconstituting 
genetical and/or chemical modified protein gates, where the diffusion of molecules can be 
triggered by a certain stimulus.  
An example for chemically engineered proteins embedded in polymersomes, describes the 
targeted modification of the lysin residues found inside the channel of FhuA in order to build a 
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reduction-triggered release system.77 The chemical labels bind to the key amino acids and block 
the molecule passage through the pore until dithiothreitol (DTT) addition, that induces the 
cleavage of the labels. An example for genetic modification of membrane proteins, presents a 
mutant type of OmpF, where cysteine have been induced by point mutation.12 In order to 
achieve stimuli responsive permeability of the vesicles, different molecular caps are linked to 
the thiol group of the cysteine. 
Besides controllable permeability, the polymersome membrane can be functionalized with 
membrane proteins for performing distinct biochemical reactions. One approach utilizes the 
simultaneous incorporation of a light driven proton pump bacteriorhodopsin (BR) together with 
the molecular motor protein F0F1-ATP synthase. Via cascade reaction triggered by external 
illumination, the photon energy is transformed into chemical energy. BR builds up a proton 
gradient across the polymer membrane which subsequently supports the catalyzed conversion 
of ADP into ATP, the universal energy source in cells.85-87 
All these examples confirm that the concept of functionalizing polymersomes by the 
reconstitution of proteins into the membrane was translated into action. Besides membrane 
proteins, lots of different catalytical active biomolecules, like enzymes, were used for equipping 
polymersomes for comprehensive biorelated processes, introduced in the following chapter. 
 
Polymersomes equipped with catalytic biomolecules 
Polymersomes offer a great potential to load hydrophilic cargoes in the aqueous core and 
hydrophobic parts in the synthetic membrane, respectively.88 Via thin-film rehydration method 
hydrophilic compounds, such as enzymes, are added to the aqueous phase (rehydration buffer) 
and then are passively transferred into the polymersomes.  
In contrast to enzymes free in solution, enzymes encapsulated inside polymersomes are 
protected from denaturation by environmental conditions and exhibit prolonged activity. 
Examples of enzymes are protease89, horseradish peroxidase12, 90, uricase and superoxide 
dismutase91 that have been encapsulated in polymersomes for developing catalytic 
nanocompartments (CNCs). Furthermore, the enzyme NADH:Ubiquinone oxidoreductase 
complex I has been functionally reconstituted in the membrane for creating an active surface 
that mediates the electron transfer from NADH to ubiquinon.92Besides enzymes, other active 
biomolecules have been encapsulated in polymersomes like Rose Bengal Bovine serum 
conjugate serving as photosensitizer93, or haemoglobin as oxygen carrier.94 The concept behind 
of the 
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Even further, it was possible to combine different CNCs working in cascade reactions or to 
entrap simultaneously more than one enzyme inside the cavity of one CNC.90, 95 Mostly, such 
bioactive polymersomes were also functionalized with (modified) membrane proteins to enable 
the (controlled) diffusion of external substrates and products formed by enzymatic reactions 
inside the compartments.90 
 
Characterization of bioactive polymersomes 
The different characteristics of bioactive polymersomes, like size, vesicular nanostructure, 
homogeneity and surface charge have to be confirmed and analyzed.  Overall, there are two key 
techniques, light scattering and microscopy. 
Nanotracking particle analysis (NTA), static and dynamic light scattering (SLS and DLS) are 
often used in combination to determine the size distribution, concentration and architecture of 
polymer self-assemblies (hollow sphere or solid particle). By measuring electronic mobility of 
polymersomes between two electrodes, the resulting zeta potential reveals information about 
the surface charge.96, 97 
Confocal laser scanning microscopy (CLSM) is a frequently used optical imaging technique to 
visualize nanostructures that are labelled with fluorophores. CLSM allows the visualization of 
fluorescently labelled polymersomes located inside mirco-sized structures (like cells).98 In case 
of reconstituted membrane proteins in polymersomes, fluorescence correlation spectroscopy 
(FCS) analyzes how many biomolecules are incorporated if they have been fluorescently 
labelled. FCS measures the diffusion time of fluorescence objects at already low nanomolar 
concentrations through a small confocal volume where the size and concentrations can be 
determined.99-103  
 
Prominent potential applications  
Due to designable multifunctionalities, bioactive nanocompartments, especially polymersomes 
are applied intensively in a lot of different medical (nanomedicine) and scientific research 
domains (nanomaterials). By taking a closer look, the detailed application methods of 
micelles/nanoparticle-based bioactive compartments differ from vesicle-based systems. In 
order to release the cargo with selective responses and functions, solid structures like 
micelles/nanoparticles have to decompose. Encapsulated biocompounds in vesicles are active 
and are able to move freely inside the cavity. In addition to this, the synthetic membrane of the 
vesicles can be designed to show selective permeability towards particular signals and 
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molecules, which allows a strong functionality without losing the initial structure of the 
compartment.  
 
Drug delivery systems 
Polymersomes are an efficient therapeutical delivery system. They are able to incorporate two 
or more agents, enhance water-solubility of drugs, improve the drugs’ half-life in blood 
circulation and achieve a controlled drug release and targeted delivery (Figure 5).46, 67, 104, 105 
All these properties minimize the side effects and toxicity of the drugs and lowers the frequency 
of taking the medication.  
In the past few decades, a large number of therapeutics based on bioactive nanocompartment 
has been clinically approved and a few pioneering systems became commercially available. In 
near feature the number of such drug delivery systems will increase strongly. Among these 
systems, the polymeric and liposomal (lipidic vesicles) platforms present the main elements 
with ca. 80%.106 The unique properties of liposomes are remarkable and their popularity in 
therapeutics has been still growing fast. These vesicles are able to encapsulate successfully both 
hydrophilic and hydrophobic compounds, they can be functionalized by designed ligands for 
achieving targeted binding on particular cells, and much more talents are investigated. A very 
interesting strategy describes the equipment of liposomes with biocompatible polymers, like 
polyethylene glycol (PEG), to prolong their half-life in vivo. This technique was also adapted 
for nanoparticle-based therapeutics, especially for delivering sensitive anticancer 
chemotherapeutic drugs with adverse side effects.106  
 
 
Figure 5. Schematic representation of polymersomes applied as drug delivery systems – By 
encapsulation of the drug into the polymersomes it is protected from external compounds. Upon 
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a certain stimulus the drug is relaused from the vesicles. Adapted from Onaca with 
permission.107 
 
Consequently, the next advancement in drug delivery systems are vesicles based on polymers 
only. These polymersomes show the same skills as liposomes and more.108 Research over the 
last two decades has yielded significant progress in the development of polymersomes for drug 
delivery. The vesicle membrane contain stimuli-responsive polymers resulting in a 
physical/chemical change or disruption in the structure to release the cargo (drug).109 Examples 
for the stimulus are light110, 111, biomolecules112, 113, temperature114, 115, pH116-118, reductive 
environment119, 120 and magnetic fields.121, 122 Additionally, the enhanced stability of 
polymersomes, half-life and surface properties support greatly the modification with ligands 
(antibodies, receptors for parasite binding) and justify polymersomes as a very promising tool 
in therapeutics.123, 124 
 
Sensing polymersomes  
In this part, two different categories of polymersomes with detecting skills are distinguished. 
The first category comprises nanovesicles that create a measurable signal as a response to a 
certain stimulus. However, during this process the structures disassemble, like in case of drug 
delivery systems. Those compartments are mostly applied as direct detection or imaging 
contrast agents to identify irregular fragments in the body.124-128  
The second category describes polymersomes that stay intact, and can function as applicable 
sensors. As polymersomes form a more robust membrane than liposomes, they are eligible for 
the second category, which presents the emphasis of this thesis and is further discussed in detail 
regarding bioactivity in chapter 4.129, 130 
In diagnostics, synthetic vesicles are used for a selective and local detection of specific 
pathological disease-related conditions, especially for tumor cells causing change in pH, redox 
potential or glucose concentration. As the sensors are expected to maintain their structure and 
function, polymersomes attract most of the attention. The additional modification of the 
polymersomes with biomolecules results in nanocompartments exhibiting cellular and 
molecular functions. Such bioactive polymersomes or biohybrid systems, contain synthetic 
polymers and biological components (proteins, enzymes) and are valuable candidates as 
nanosensors (Figure 6). Their structural integrity and stimuli responsiveness are prevented over 
a longer period of time. The sensing mechanism is based either on the insertion/attachment of 
stimuli-responsive biomolecules (proteins) and/or on the encapsulation of active 
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(bio)molecules (dyes, enzymes). Inside the vesicles, a signal like colorimetric change or 
fluorescence is produced for detection.75, 131-134 
 
Figure 6. Schematic representation of a potential ion sensor based on polymersomes – Design 
of Ca2+-selective permeable membranes by insertion of ionomycin into polymersomes. Adapted 
from Lomora with permission.80 
 
Polymersomes with biopores reconstituted in the membrane are promising candidates for 
sensing pathological conditions. For example, the membrane proteins aquaglyceroporin GlpF 
has been successfully inserted in the polymer membrane and allow selective permeabilization 
for small sugar alcohols.135 The predominant membrane protein is OmpF and OmpF mutants.12, 
15, 75 Due to its stability, triggerable functionalities of OmpF can be engineered which is 
described in the third chapter in detail.  
Besides membrane proteins, chemically tuned polymers forming the membrane are able to 
support the selective permeability of the vesicles due to their chemical nature causing 
attracting/distracting forces with external compounds.66 
 
Artificial organelles 
Catalytic polymersomes have remarkable abilities as sensors and concurrently as simplified 
artificial organelles. Such nanocompartments respond to a stimulus in a bioinspired manner 
related to the behavior of natural organelles in cells.45, 95, 136  
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Polymersomes equipped with active biomolecules (catalytic nanocompartments) are useful 
vehicles serving as artificial organelles. The idea of artificial organelles describes such catalytic 
nanocompartments (CNCs) that have been taken up by cells and performed particular reactions 
inside them. The aim is to replace damaged or missing cellular pathways with implanted 
artificial organelles and to facilitate techniques based on metabolic reactions steps used in the 
fields of tissue engineering and synthetic biology.71, 137  
One famous example are catalytic nanocompartments working as artificial peroxisomes in cells. 
Natural occurring peroxisomes contribute to a defense mechanism against reactive oxygen 
species (ROS). In order to achieve such a detoxifying process, two antioxidant enzymes were 
encapsulated into polymersomes transforming superoxide radicals and H2O2 into oxygen and 
water via a 2-step, cascade reaction. OmpF serving as the gate for substrates and products was 
reconstituted into the polymeric membrane to allow a constant exchange with the external 
environment. In case of a high ROS occurrence (oxidative stress) associated to different 
diseases like arthritis, the artificial peroxisome as cellular implant is expected support the 
overextended organism and to recover the metabolic balance.136 
 
Compartmentalization within cell-like compartments  
In real cells, metabolic reactions are performed in organelles (subcompartmentalization) in 
order to provide the perfect conditions (pH, concentration of ions) appropriate for each specific 
need. This complex architecture performing different biochemical reactions simultaneously is 
the inspiration of developing cell-mimicking platforms. Cell-mimicking platforms became 
indispensable as tools in various scientific domains such as the design of microrecators and the 
investigation of cellular processes. Therefore, the aim is to develop cell-mimicking 
compartments combining different cell functions and including complex compartmentalization 
like in living cells. 
This functional principle of subcompartmentalization in real cells can be adopted for 
microcompartments, like synthetic GUVs (Figure 7) to design cell-mimics.39, 138, 139  The 
prospective challenge is to create so-called artificial cells with multicompartmentalization 
where diverse subcompartments with different activities and membrane permeabilization are 
able to perform metabolic pathways. Here, different kinds of nanosized CNCs (liposomes or 
polymersomes) serve as subcompartments in the GUVs and catalyze one reaction or a cascade 
reaction in case of multicompartmentalization (two or more different CNCs inside the 
cavity).140 Due to the high stability, GUVs formed by polymers attact a lot of attention in this 
research field. The co-laoding of such GUVs with different nanoobjects is achieved 
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simultaneously by using film rehydration method. For example, an external signal can be 
transduced between structurally diverse nanocompartments (particles, vesicles) serving as 
artificial organelles in GUVs. By supplying this system with an additional cytoskeleton 
component (actin), the multicompartment is able to form an internal cytoskeletal network (actin 
polymerization) via ion channel recruitment from the environment.141 The preparation of 
multicompartments by film rehydration method, however, shows some challenges like the low 
encapsulated content and limitations in membrane compositions. To achieve a fine control of 
these parameters, the preparation of multicompartments by double emulsion microfluidics 
attacts a lot of attention.139 The resulting GUVs are able to serve as a ideal cell-sized template 
with a very narrow distribution of GUV size and internal content.142 
 
 
Figure 7. Subcompartmentalization within GUVs – Schematic representation of 
multicompartment system composed of reduction sensitive subcompartments for triggered 
enzymatic activity and ion channel recruitment, encapsulated within polymeric giant 
unilamellar vesicles. The reducing agent DTT was used as the signal (red arrow) that passively 
traverses the polymeric GUV membrane without addition of biopores or channels. Adapted 
from Thamboo et al. with permission.140  
 
Additionally, multicompartmentalization can be performed by transferring bioreactive 
polymersomes in GPMVs to create bioinspired molecular factories and customizable cell 
mimics. The advantage of GPMVs over all GUVs is the very cell-similiar composition that 
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cannot be achieved via bottom-up approaches. The GPMVs are directly formed by cells. Recent 
studies further showed that polymersomes inside GPMVs are able to perform distinct catalytic 
reactions and demonstrate that also GPMVs can be supplemented with nanocompartments 
serving as artificial organelles.14 In fourth chapter, the procedure of transferring nanoscale 
objects from cells into GPMVs is discussed in detail with the focus on optimized conditions for 




GUVs as cell-like compartments based on lipid and polymer 
membranes 
 
Lipid- or polymer-based compartments at the microscale, are termed giant unilamellar vesicles 
(GUVs). GUVs are a very promising platform for the reconstitution of a wide variety of 
membrane or peripheral proteins resulting in complex biomimics. Due to this, GUVs have been 
widely used for developing artificial cells models in order to understand cellular functions and 
to investigate bilayer interactions within the membrane.  In the 19th century, cell-free enzymatic 
reactions have been discovered for the first time, showing that biochemical reactions don’t 
necessarily require the whole living organism.143 In the following century, the concept of 
building up synthetic vesicles at the microscale via “bottom up” approach attracted a lot of 
attention.144 These compartments include lipid- and polymer-based GUVs138, 145-148 lipid coated 
porous silica nanoparticles149, layer-by-layer capsules150, membrane free microdroplets, and 
microscaled proteinosomes.151  
GUVs are regularly used in synthetic biology. They are able incorporate a huge number of 
different biomolecules or inorganic compounds that undergo, initiate or catalyze distinct 
reactions in a very effective manner (Figure 8). The most prominent reactions are those 
catalyzed by stable enzymes found in the cavity of biomimicking compartments. These cell 
mimics have a great potential for synthetizing proteins152, synthetic polymers153, and RNAs.154 
Concurrently, GUVs are a valuable tool for determining the molecular parameters supporting a 
single, systematically isolated reaction existing within the whole complex metabolism. In cells, 
many interactions between different biomolecules or assemblies take place at the same time 
and it is impossible to define each single pathway.155 However, GUVs are simultaneously cell-
like and simple enough to gain new aspects of essential biological processes without giving 
biased measurement data. 
Another advantage of GUVs over living cells is the facilitated handling. Cells have to be 
cultivated under certain conditions including temperature, CO2 atmosphere and nutrition. The 
stability and working efficiency of the biomimicking compartments, lacking of an own 
metabolism, are commonly independent of the external environment.  
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Figure 8. Comparison of real cell and synthetic GUV –  Design of (left) a natural cell and 
(right) a synthetic giant unilamellar vesicle (GUV) with encapsulated enzymes engineered for 
selective permeability to substrates and products based on reconstitution of outer membrane 
protein F (OmpF) to visualize a model enzymatic reaction inside the cavity. Adapted from Garni 
with permission.13  
 
Why cell-like compartments? 
A central objective in biology is the template-dependent generation of the inseparably 
associated units of life. The cells of all organisms consist of four essential macromolecular 
components: Lipids, glycans, nucleic acids and proteins (Figure 9).14, 156  Within living cells, 
the fundamental builidng blocks form highly complex, but well-organized structures that work 
with remarkable efficiency and precision on the molecular and atomic level.157 I order to cur 
diseases effectively, we have to acknowledge and understand the fundamental building blocks 
of life first; how they are constructed and interact during the cell metabolism with all its diverse 




Figure 9. The molecular building blocks of life – The four fundamental macromolecular 
components (lipids, glycans, nucleic acids and proteins) are built up by 68 molecules.  Adapted 
from  Marth with permission.156 
 
To get a better insight, cell-mimicking compartments have been created. The compartments 
show a high complexity and multifunctionality similar to living cells. They have distinct cell-
like functionalities and are able to perform complex biochemical reactions and 
transformations.158 Based on biomimicking compartments as platform, researchers could yield 
the information how metabolism, the fundamental prerequisite of living organisms, arose in 
organic frameworks. Overall, biomimicking compartments have great a potential in lots of 
interdisciplinary scientific fields in biotechnology, medicine and material science.138, 159, 160 
Besides treating diseases, it is possible that such synthetic biomimicking platforms will enable 
to assemble alternative tissues and organs. So, necessary transplantations won’t be longer 
dependent on finding the right donors.  
The living cells were discovered two centuries ago and up to now, various different 
achievements have been made that will bring the researchers’ ambitious dreams closer of 
designing and creating cell mimics.158 The main strategies for building up cell mimics and 
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biomimicking compartments in the microscale are: i) the “bottom-up” and ii) the “top-down” 
approaches. The “top-down” approach allows the manipulation and reengineering of the cells 
by using well-developed biotechnological tools.161 This technique is based on the genetic 
modification of living cells (i.e. stem cell) to create so-called “minimal cells”.158, 162  In general, 
the “top-down” approach is suitable for designing fully functional cell mimics. The resulting 
artificial cell models are customized to the respective requested objective and fulfill different 
requirements. Their complexity is closer to the non-engineered cells than the compartments 
obtained from “bottom-up” approach. However, like in case of real cells, the high complexity 
can be a disadvantage as it is difficult to follow a distinct biochemical pathway.162, 163   
The “bottom-up” approach starts with single components on the molecular level that are built 
up to consistent structures in vitro. Synthetic compounds such as lipids or polymers are 
assembled form the membrane of the micro-sized compartment which can be equipped with 
biological molecules for functionalization. Various different combinations have already been 
applied to create cell mimics that are able to accomplish biorelevant processes and biochemical 
reactions for defining structural parameters. Scientific disciplines using these cell-like 
compartments focus on designing simplified cell mimics to gain insights into the function of 
the very complex metabolism. In contrast to a living organism, where millions of actions take 
place, the “bottom-up” cell mimics undergo a limited number of processes that can be observed 
carefully and precisely in order to disclose basic working principles in biology.145, 146, 164-166  
As this work focuses primarily on GPMVs as cell-mimicking platform, the basics and concept 
of lipid and poymer-basased GUVs are shortly summarized in the following.  
 
Building up GUVs 
Lipid-based GUVs 
Lipidic GUVs have a size of at least 1 µm and the membrane is based on phospholipids forming 
a thin bilayer of approximately only 5 nm, similar to living cells. Latest research results have 
advanced lipid GUV systems including complex lipid compositions. Such GUVs exhibit 
controlled asymmetries and allow detailed studies of membrane protein structures and the 
corresponding functionality in cell-like model membranes.167 
Besides phospholipids, minimal artificial cells incorporate additive biomolecules, such as DNA 
or proteins to perform elemental cellular functions. Two prominent technologies for producing 
such lipid-based artificial cells are “bottom-up” approaches, where membrane proteins 
extracted from living cells are reconstituted into GUVs. The compartments were formed by 
either the gentle hydration method (conventional method)80, 168 or by microfluidic.169-171 
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Compared to the hydration method, microfluidic technology achieves the formation of very 
monodisperse, unilamellar giant lipid vesicles in higher concentrations and with a more 
efficient encapsulation rate. 
 
Polymer-based GUVs  
Up to now, several biopores have been reconstituted in polymer GUVs in order to allow 
controlled permeabilization towards ions and/or molecules. The conventional formation of lipid 
GUVs can be easily adapted to polymer GUV formation, if the differences in thermodynamic 
self-assembly of polymers have to be taken into account. Additionally, microfluidic double 
emulsion processes were successfully developed in order to produce polymer GUVs with 
diverse biofunctionalities including enzymes.142  
However, lots of protein reconstitutions successfully implemented in lipid membranes, are not 
readily applicable to synthetic copolymer membranes; the different physicochemical properties 
of polymer membranes strongly affect the interactions between membrane and protein. 
Compared to lipid membranes, synthetic polymer membranes have a much higher molecular 
mass and a considerably thicker membrane with more limited flexibility and fluidity. These 
properties result in a length mismatch between the hydrophobic domain of the copolymer 
membrane and the membrane-spanning hydrophobic domain of the protein. Additionally, the 
polymer membrane is more fragile towards detergent-containing solutions, in which isolated 
membrane proteins are commonly stored in. To overcome this issue, hybrid GUVs were formed 
by phospholipid and block copolymers. The membrane consists of a lipid/polymer mixture that 
combines the biocompatibility and cell-membrane-resemblance of lipids with the robustness 
and chemical versatility of polymer membranes.13, 79, 172   
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GPMVs as cell mimics  
 
Synthetic GUVs represent the simplest cell-like platform due to limited complexity regarding 
internal composition. In contrast to GUVs, giant plasma membrane vesicles (GPMVs) are 
directly formed by cells and thus, contain most of the cellular components expect larger 
organelles, polymerized cytoskeletal elements or internal membranes. GPMVs are filled with 
cytoplasm and its membranes are rich in lipid and protein components corresponding to the 
plasma membrane of the donor cells.173  GPMVs as non-living organisms, are probably the 
most innovative solution for creating “biological” cell-mimicking compartments, with partly 
identic cellular composition. Although GPMVs are the closest and most similar to cells up to 
today, they have been unnoticed as cell-mimics for years. 
In this work, “bottom up” and “top-down” were combined to create GPMVs as cell-like 
compartments. This approach uses eucaryotic cells that have taken up non-natural occurring 
components for distinct functionality. These modified cells are then treated in order to produce 
very cell-like but not living microscale compartments bearing the synthetic components as well. 
Here, the complexity and functionality of GPMVs can be enhanced in a controlled manner by 
systematically increasing the number the components inside as it was performed with GUV 
modifications. Due to this, the construction of a cell-like compartment is continuously 
approximating real cells. 
 
GPMVs as promising cell-like compartment derived directly from cells  
Naturally occurring vesicles produced by cells are an attractive alternative to synthetic 
compartments. For example, exosomes have a great potential for drug delivery systems as they 
achieve targeted delivery which still presents a challenge for other cell-mimicking vesicles.174-
176 However, the drawback of exosomes are their limitations regarding production and 
modification. Therefore vesicles formed from cellular oganelles with promising properties for 
additional modification have been investigated for their potential as exosome-mimics.177, 178 
Additonally, GPMVs have been considered as promising alternative to exosomes and present 
the focus of this chapter. As the name indicates, GPMVs are derived from the plasma membrane 
of cells. GPMVs are naturally formed by cells if they are exposed to huge stress such as lack of 
food. In contrast to exosomes, the formation of GPMVs and the subsequent isolation from the 
donor cells have already been optimized for high yields under laboratory conditions. Here, 
GPMVs are systematically formed by treating the cells with very high salt concentrations, 
reducing agents or laser irradiation causing local delamination of the plasma membrane from 
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the underlying cytoskeleton.179-181 The ensuing protrusions of the cell are then filled by a 
passive flow of the cytoplasma resulting in a GPMV.182-184 GPMVs contain almost all cellular 
components expect larger organelles such as the nucleus or Golgi apparatus regarding the inner 
composition as well as the outer membrane structure.181, 183, 185, 186 
GPMVs were used as platform for studying the compositional and structural characteristics of 
the plasma membrane before and after interactions with external compounds.187-189 In addition, 
a detailed investigation of the properties of the membrane associated IgE-receptor complex was 
described.190 Another research area also started dealing with the development and 
characterization of planar supported membranes received from GPMVs and exploited GPMVs 
as host-cell model for drug delivery.182, 191 Studies regarding the high potential of GPMVs as 
artificial cells are still very rare.184, 192 However, in fourth chapter of this work we describe a 
new promising strategy of using GPMVs as cell-mimicking systems in order to overcome the 
current challenges of designing ideal cell-like compartments.  
 
 
Figure 10. GPMVs formed from Caco-2 cell line – Scale bar 15 µm. 
 
Characterization of GPMVs 
As GPMVs are vesicular structures in the micrometer range, they are easily visible under an 
optical microscope (Figure 10). Furthermore, it is possible to directly observe certain 
interactions of encapsulated solutes and/or structures in real-time. Light/fluorescence/confocal 
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laser scanning microscopy is a suitable technique to visualize cells forming GPMVs and follow 
GPMVs isolated from cells. In order to analyze fluorescently labelled nanoscale objects 
(peptides, polymersomes or nanoparticles) inside GPMVs, CLSM and flow cytometry (a light 
scattering technique)193, 194 provide data in terms of GPMV size and fluorescent properties.59 
CLSM uses a spatial pinhole placed at the confocal plane of the lens for reconstructing the 3D 
architectures from images that are acquired with optical sectioning.  
Membrane properties, such as permeability, elasticity, and surface charge are important 
parameters in many applications. Several methods have been applied to characterize GUVs but 
also GPMVs including various electron microscopy (EM) techniques, which allow direct visual 
inspection of the structures with high resolution. Here, an electron beam is driven through the 
sample and the resulting interactions are recorded. In contrast to the conventional transmission 
or scanning EM, cryo-EM provides information on size, morphology, and membrane thickness 
of the vesicular assemblies as for this method drying or staining of artifacts is not necessary.59 
In addition to microscopy techniques, Förster resonance energy transfer (FRET) yield 
quantitative information about dimerization propensities of fluorescent tagged proteins within 
the membrane. Further mechanical characteristics of GPMVs ca be analyzed by Atomic force 










Triggerable permeability of catalytic polymersomes provides many opportunities for controlled 
activation of enzymatic reactions inside. One established approach is to insert OmpF in the 
membrane. OmpF is a very robust protein gate that is can be isolated fast from bacteria and 
allows an easy handling and modification. Furthermore, mutants of OmpF have been 
successfully expressed allowing diverse additonal modifications and functinalities. The 
modification of reconstituted OmpF mutants enables a  molecule passage through the polymeric 
membrane controlled by stimuli-responsiveness of the mutant or of the molecular caps that have 
been selectively attached to the OmpF mutant. So far, OmpF has been modified with 
commercially available molecules or peptides, serving as molecular caps, that covalently bind 
to genetically engineered cysteine in the eyelet region. The drawback of this approach is the 
supplier-depended variety of potential linkers. Due to this, a refined strategy describing a more 
practicable preparation of stimuli-responsive molecules in the laboratory is needed. The new 
approach should be based on a more customizable solution where different factors can be taken 
into account during the designing process and the synthesis of molecule/linker for OmpF 
mutants. For example, it is important that the linker is of an appropriate size to block OmpF 
pores efficiently. For this reason, diverse structures of potential molecules such as coiling, or 
spatial orientation in aqueous media with a physiological pH, have to be respected. In order to 
apply this technique not only OmpF, but to other (more fragile) membrane proteins, it is also 
important to consider the water solubility of the product. For most proteins, harsh conditions 
like organic solvents, temperature, pH habe to avoided to protect the structure and functionality. 
Additionally, further potential applications of polymersomes with a controlled permeability 
should be considered. For example, polymersomes with encapsulated catalysts and with 
stimuli-responsive permeability present a smart system that allows a precisly initiated catalytic 
reaction and shows a promising  potential in catalysis.  Moreover, the encapsulation of 
polymersomes prolonges the activity of sensitive catalysts, such as enzymes, as the cargo is 
protected from the environment by the robust polymeric membrane. 
 
GPMVs 
Due to their composition, GPMVs represent a very promising biomimicking platform with the 
closest similarity to real cells. However, most reported studies about GPMVs focused on their 
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structure and composition and not on their development as cell-mimicking compartments. Until 
today, there are still many open questions regarding the capability as cell-like templates and if 
a controlled modification of GPMVs is feasable. Therefore, it is essential to investigate the 
modification of GPMVs, meaning the equipment with external, not biological nanoobjects 
inside the cavity. One established sprocedure decribes the modification of GPMVs with 
different nanoscale objects that have been taken-up by cells and transfer subsequently into 
GPMVs during the formation process. Consequently, the next step is to study how GPMVs can 
be modified efficiently with non-cellular nanoobjects. Therefore, different impact factors 
playing an important role during the modification have factors have to be extracted and 
evaluated. Besides different physical and chemical properties of the nanoobjects, the impact of 






AIM OF THE THESIS 
 
In this work, biomimcking and bioactive compartments in the nano- and microscale are 
designed and modified to create i) catalytic polymersomes with stimuli-responsive membrane 
permeabilty and ii) GPMVs supplemented with NPs in high efficiency. 
The first project, describes a new, chemistry-oriented strategy for triggerable activity of 
polymersomes (catalytic nanocompartments). Our aim is to chemically modify the membrane 
protein OmpF with a small organic linker and to subsequently reconstitute this OmpF as a pore 
into the polymeric membrane of the compartments. The linker is  expected to block the diffusion 
of small molecules through the OmpF. However, in presence of a certain stimulus, the linker 
should be cleaved to open the OmpF pores. As the permeability is controlled by a stimuli-
responsive membrane protein, the structure of the vesicles is preserved and allows diverse 
important applications, like artificial organelles or material for nanosensing. Our stategy to 
create such biohybrid polymersomes is based on the modification of the membrane protein  
OmpF serving as model protein. Additionally, our aim is to establish a technique for 
synthesizing customizable linkers suitable for all kinds of proteins. In order to produce a linker, 
completely soluble in water, we combine tools of organic chemistry synthesis with crosslinkers 
used commonly for bioconjugation as starting material. The requirement of the resutling linker 
was the application under protein-appropriate conditions without destroying the structure or 
functionality, meaning avoiding harsh organic solvents or pH values below or above 
physilogical conditions.  
The aim of the second project is to investigate the potential of GPMVs as customizeable cell-
like compartments. We are convinced that GPMVs are great candidates as cell mimics as they 
are directly formed from cells and thus, present the closest cell-mimicking compartments. In 
this work, we want to examine how GPMVs can be modified to obtain platforms applicable for 
the investigation of distinct cellular processes and highly complex biochemical reactions. 
Therefore, we collect new insights regarding the modification of GPMVs with NPs serving as 
a model for nanocompartments. Due to the fact that this research field is almost untouched, 
fundamental questions regarding: i) the effect of concentration, ii) the surface charge and iii) 
the size of such transferred nanoobjects were adressed and analyzed in detail. Those parameters 
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are thouroughly investigated via monitoring the distribution of different NPs inside at least 250 





MEMBRANE PROTEIN CHANNEL EQUIPPED WITH 
A CLEAVABLE LINKER TO ACTIVATE SENSITIVE 
CATALYSTS INSIDE POLYMERSOMES 
 
Significant progress in the functionalization of polymersomes has been obtained by embedding 
modified proteins into the membrane for stimuli-responsive permeability. Inside the 
polymersomes, enzymes are encapsulated and catalyze distinct reactions with molecules 
diffusing through the membrane. Due to the resulting triggerable activity, such bioinspired 
vesicles are promising tools for catalysis. In this chapter, we introduce here an efficient closing-
opening method for polymersomes that contain sensitive catalysts and so achieve a controlled 
and extended catalytic activity. We developed a chemistry-oriented approach for modifying a 
membrane protein (OmpF) resulting in stimuli-responsive pore opening within the membrane 
of the polymeric compartments. We synthesized a diol-containing linker that selectively binds 
to the pores, blocking them. In the presence of an external stimulus (periodate), the linker is 
cleaved allowing the diffusion of substrate through the pores to the interior where the 
encapsulated enzyme catalyzes a reaction to colorimetric products. Besides the precise closing 
and opening of the pores controlling the catalytic activity, the oxidation by periodate 
guarantees the cleavage of the linker under mild conditions, where sensitive biomolecules like 
























This study has been published: Luisa Zartner, Viviana Maffeis, Cora-Ann Schoenenberger, Ionel Adrian Dinu, 
Cornelia G. Palivan*. Membrane protein channels equipped with a cleavable linker for inducing catalysis inside 
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Motivation and challenges ahead 
Diverse stimuli-responsive polymersomes are specifically engineered to protect their cargo 
while supporting a triggered functionality when the stimulus is present in the environment.27, 
109, 126, 149, 196, 197 Due to this, such polymersomes, have an increasing potential for applications 
in catalysis as they are able to change their permeability upon the presence of a stimulus in their 
environment while preserving their architecture: the increased permeability favors the 
molecular flow through the synthetic membrane, which will trigger an in situ functionality, as 
for example by starting a specific reaction of the encapsulated active compounds.129, 130  One 
strategy to generate stimuli-responsive polymersomes with preserved architecture is to take 
advantage of stimuli-responsive copolymers to form vesicles that shrink or swell upon an 
external signal (like protons, CO2 or change in temperature).66, 115, 198 A complementary 
strategy, which is “bioinspired” by the cell membrane known to contain a variety of membrane 
proteins that are essential for a molecular transport through, hinges on reconstitution of 
membrane proteins or small polypeptides into the polymeric membrane to achieve a desired 
permeability.82, 129 For example, membrane protein channels, such as the outer membrane 
protein F (OmpF), enable the diffusion of molecules with a size up to the pore diameter, 74, 75, 
90, 133 while others, such as aquaglyceroporin or gramicidin, only allow diffusion of specific 
molecules or ions.79, 135 A step further in developing stimuli-responsive membrane 
permeabilization was achieved by modification of the membrane proteins such to become either 
a “valve” or a “gate”. By attaching a pH-sensitive GALA polypeptide to OmpF, this one has 
been rendered a pH-triggerable valve, which served to open/close the polymersome when it has 
been inserted in the membrane.199 Alternatively, when molecules were covalently bound to a 
double mutant of OmpF, this one became a gate when inserted into the membrane of 
polymersomes, the pores being closed and opened when the molecules were cleaved by upon 
the presence of a specific stimulus.15 Furthermore, polymersomes equipped with stimuli-
responsive OmpF gates and loaded with specific enzymes served for development of catalytic 
nanocompartments (CNCs) with triggered activity: only when the gate was open by the 
presence of a specific stimulus, which cleaved the molecules closing the pore, the enzymes 
encapsulated inside started to perform their biologic function as the substrates freely diffused 
through.12, 15  
Here we enlarge the concept of CNCs with triggered activity by developing a chemistry-based 
strategy for modifying membrane protein channels to achieve stimuli-responsive opening of the 
pores inserted in the membrane of the compartments that allows the substrates to enter and start 
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the in situ reaction. We chemically modified a double mutant of OmpF under mild conditions 
by covalently binding a linker rationally designed and synthesized to render this channel porin 
a “gate” opening in the presence of periodate, an important oxidant for the selective oxidation 
of polysaccharides and glycopeptides.200, 201 We chose OmpF as model of membrane protein 
channels as it is a well characterized porin in terms of structural and functional 
characteristics.202 The linker was designed to bind to specific amino acids K89C R270C of 
OmpF, which are located at the pore opening, and to be cleavable by a particular, small 
molecule (periodate). We chose periodate as it serves for oxidative cleavage of the linker under 
mild conditions in aqueous solutions where membrane proteins are not affected and remain 
functional. Additionally, we were interested to synthesize a water soluble linker to enable 
applications without the use of organic solvents that are expected to affect membrane proteins.  
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Modification of OmpF with a small organic compound for triggerable 
activation of catalytic polymersomes 
 
OmpF monomer has the structure of hollow beta barrel, embedded in the membrane with a 
diameter of around 30 Å (Figure 11A), enabling diffusion of small (generally under 600 Da) 
water-soluble molecules in both directions.203, 204 To achieve the chemical modification 
necessary to bind the linker, we used OmpF-M, a genetically modified porin that features two 
cysteine (Cys) residues opposing each other in the 'eyelet' region of the pore (OmpF double 
mutant K89C R270C, OmpF-M).19, 20 The thiol groups of these Cys moieties are exposed and 
can be readily modified (Figure 11).  
Figure 11. OmpF structure and the linker design – A) PyMol ribbon representation of OmpF-
M secondary structure reveals a distance of about 30 Å between the side groups of the two Cys; 
B) Left: Chemical structure of the designed linker with maleimide groups indicated in green, 
fluorophores in pink and the diol unit in blue. Right: the linker length corresponds to the 
distance between the two opposing Cys of OmpF-M, as estimated by PyMol modeling. 
To block OmpF pores by covalent binding of an organic compound and induce a controlled 
opening by the presence of periodate, different requirements have to be considered in terms of 
the size and conformation of the linker, its accessibility and efficient cleavage for a stimuli-
responsive opening of the OmpF pores. First, the steric size and conformation of the linker 
should efficiently block the pore and second, both ends of the linker should be bound to OmpF 
to minimize the freedom of rotation. Thus, we opted to synthesize a small organic compound 
to provide a more rigid structure compared to coiled macromolecules where the spatial 
orientation and folding is more difficult to predict.205, 206 The length of the linker was designed 
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to span the diameter of the OmpF-M pore at the site of the two Cys moieties, i.e. approximately 
30 Å, whereas a maleimide group at each linker end was inserted to favor the reaction with thiol 
side chain of the two cysteines (Figure 11B).207 Third, an important factor to consider in the 
linker design was the periodate-responsiveness that would result in its oxidative cleavage to 
unblock of the OmpF ’gate’. Hence, we introduced a vicinal diol unit with a periodate-sensitive 
C-C bond in the middle of the symmetric linker (Figure 11B, in blue). Periodate oxidizes the 
diol into the corresponding carbonyl groups under mild conditions, at pH = 7 and room 
temperature.208 Oxidation by periodate is predicted to produce two fragments able to rotate 
freely as they are bound only at one end to a Cys side chain: the periodate-triggered cleavage 
of the linker releases the OmpF pore obstruction. Finally, our linker design included two 
fluorophore (cyanine3 dye) side chains both to create a bulkier structure for a more efficient 
pore blocking and to allow detection by fluorescence-based techniques. Synthesis of the 
periodate-responsive linker was performed in three consecutive steps (Scheme 1). We started 
from the vicinal diol element of a disuccinimidyl derivative of tartaric acid and symmetrically 
built up the linker on both sides. To achieve a final linker length of approximately 30 Å, we 
coupled two cysteine molecules to the respective ends of the reactive ester, to which we then 
covalently attached cyanine3 maleimides via the thiol groups as fluorescent side chains. The 
two functional maleimide end groups of the linker were integrated using a compound 
combining maleimide with a small hydrocarbon chain and hydrazide as the second end 
functional group. The hydrazide moiety reacted selectively with the carboxylate group of the 
cysteine fragments resulting in the final linker with a length of 30 Å (Figure 11B). 
In the first step, cysteine was coupled with disuccinimidyl tartrate (DST) by the simple reaction 
of amine groups with the NHS-activated tartaric acid (Scheme 1). This step was necessary to 
introduce the reactive thiol groups, which were subsequently involved in the second reaction 
step to couple the fluorescent cyanine3 maleimide molecules. The first intermediate 
(Compound 1) was only partially purified and then used further for the synthesis of Compound 
2. Thus, the 1H-NMR spectrum of the first intermediate showed the characteristic peaks of the 
coupled cysteine found in the range of 3.45-3.30 ppm and 4.65 ppm corresponding to the 
methylene (CH2-SH) and methine (NH-CH) groups, together with the two protons (CH-CH) of 
the vicinal diol unit at 4.7-4.6 pm. Additionally, the spectrum indicated the presence of 
monofunctional product, cysteine and free N-hydroxy succinimide. The 13C-NMR spectrum 
confirmed the presence of carbons around 180-170 ppm characteristic for carbonyl moieties 
from amides and carboxylic acids, the two carbons of the vicinal diol unit around 70 ppm, and 
the two carbon atoms of the cysteine connected to the tartaric acid by amide groups at around 
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50 ppm. Analysis by ESI-MS revealed a value of m/z= 179.05, which corresponds to double 
the protonated Compound 1 [M+2H]+ and could not be assigned to DST or cysteine. Compound 
1 was used in the second reaction step aiming to induce its selective reaction with cyanine3 
maleimide, resulting in Compound 2. The 1H-NMR spectrum of Compound 2 showed that 
possible impurities resulting from the synthesis of the first intermediate were efficiently 
removed during the purification step and did not lead to any other side products nor disrupt the 
reaction affording Compound 2 (Figure S1). In addition to the protons of the vicinal diol 
element of tartaric acid and the cysteine fragments, we observed peaks in the 9.00-5.50 ppm 
range, characteristic for the heterocyclic and aromatic rings, as well as for the extended 
conjugation of the double bonds of the cyanine3 dye. The singlet peak characteristic for the two 
protons of the maleimide groups was not identified in the spectrum, indicating the complete 
coupling of cyanine3 maleimide and consequently the formation of Compound 2. According to 
the 13C-NMR spectrum, the characteristic peaks of the carbon atoms from the carboxylic acids 
and amides were visible in the 180-170 ppm range. In addition, carbon peaks of cyanine3 dye 
were observed, including peak at 168 ppm representing carboxamides, C=C groups around 
140 ppm, aromatic carbons around 120-110 ppm, aliphatic amines between 50-30 ppm, and the 
hydrocarbon chains in the 30-20 ppm range (Figure S2). Analysis of the product by MS 
(MALDI-TOF) revealed an m/z value of [M+2H]+ = 379.16, corresponding exactly to 
Compound 2. In the last synthesis step, the carboxylic acid groups of Compound 2 were 
activated by EDC to form the amine-reactive O-acyl isourea intermediate. Subsequently, the 
reaction with N-ε-maleimidocaproic acid hydrazide (EMCH) led to the formation of a 
symmetric bismaleimide linker, as confirmed by the NMR spectra (Figure S3 and Figure S4). 
In addition to the peaks that were already observed for Compound 2, the 1H-NMR spectrum 
showed peaks between 2.0-1.0 ppm, characteristic for protons of the two hydrocarbon chains 
that were introduced by reacting Compound 2 with EMCH. The hydrazide group of the 
crosslinker EMCH commonly generates a very broad peak between 4.5-3.5 ppm with an 
integral of 4, which was not found in the 1H-NMR spectrum of our final product. The 13C-NMR 
spectrum of the final linker indicated its large hydrocarbon backbone and showed the 
characteristic peaks of the two carboxamines carbons from the coupled maleimide groups 
around 165 ppm. Interestingly, the peaks of the aromatic carbons from the fluorophore were no 
longer detected. However, as the characteristic fluorescence of cyanine3 was still clearly visible 
when the linker was dissolved in the NMR-tube (Figure S4), we concluded that the absence 
represents an effect of a decreased solubility in CDCl3. Additionally, MALDI-TOF revealed 
an m/z value of [M+H]+ = 643.68, which corresponds exactly to the bismaleimide linker. 
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Scheme 1. Route of synthesis of the periodate-sensitive linker  
 
Next, we reacted the linker dissolved in water with purified recombinant OmpF-M in order to 
attach the linker and close the OmpF pores. After the labeling reaction, linker-OmpF-M solution 
was heated to 95 °C to denature all intramolecular interactions except covalent bonds and then 
analyzed by SDS-PAGE (Figure S5). We observed a single fluorescent band running with the 
apparent molecular weight of monomeric OmpF-M (about 40 kDa204, lanes 3, 4), which 
indicated a covalent binding of the fluorescent linker to OmpF-M. Therefore, an unspecific 
aggregation of the linker with the protein did not appear and the covalent binding was 
successful. 
To establish whether the linker attachment to the OmpF-M was able to i) close efficiently the 
pore and ii) control the passage through the OmpF pore in a precise manner, we prepared several 
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types of polymersomes encapsulating laccase as model for a sensitive catalyst in their aqueous 
cavity: (i) CNCs without OmpF-M pores (CNC-noOmpF-M), (ii) CNCs with reconstituted 
linker-modified OmpF-M (CNC-linker-OmpF-M), (iii) CNCs with reconstituted OmpF-M 
lacking the linker modification (CNC-OmpF-M), and (iv) CNCs with wild-type OmpF inserted 
in their membranes (CNC-OmpF-WT). We used the film rehydration method209 to form 
polymersomes from poly(2-methyl-2-oxazoline)-block-poly(dimethyl-siloxane)-block-poly(2-
methyl-2-oxazo-line), PMOXA11-b-PDMS104-b-PMOXA11. Such amphiphilic triblock 
copolymers (PMOXA-b-PDMS-b-PMOXA) are known to self-assemble into vesicles with 
membranes that are sufficiently flexible to integrate OmpF despite the hydrophobic 
mismatch.82, 83, 210, 211 The average number of MOXA and DMS repeating units in PMOXA11-
b-PDMS104-b-PMOXA11 was assessed by proton nuclear magnetic resonance (1H-NMR) 
spectroscopy (Figure S6). This method also allowed for obtaining the number-average 
molecular weight of this copolymer (Mn = 9800 g/mol), whereas a dispersity (Ð) of 1.23 was 
revealed by gel permeation chromatography (GPC) (Figure S7).  
Figure 12. Characterization of the CNCs – A) TEM micrographs of CNCs without OmpF 
(CNC-noOmpF), CNCs with linker-OmpF-M (CNC-linker-OmpF-M) inserted in the 
membrane, CNCs with OmpF-M (CNC-OmpF-M), and OmpF wild type (CNC-OmpF-WT). 
Scalebars: 200 nm. B) B) FCS curves (line) and raw data (dots) of PBS solutions of the linker 
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(pink), free linker-OmpF-M in 1% OG (blue), and CNCs with linker-OmpF-M reconstituted in 
the membrane (green), C) Light scattering parameters of CNCs without OmpF pores (CNC-
noOmpF), CNCs with inserted OmpF-M-linker (CNC-linker-OmpF-M), CNCs with inserted 
OmpF-M (CNC-OmpF-M), and CNCs with inserted wild-type OmpF (CNC-OmpF-WT). A ratio 
between the hydrodynamic radius (Rh) and radius of gyration (Rg) between 0.775 and 1 
indicates a hollow sphere architecture for all types of CNCs. Polymersome size homogeneity 
was confirmed by dynamic light scattering with a PDI = 0.2. 
 
The size and architecture of CNCs were characterized by transmission electron microscopy 
(TEM), fluorescence correlation spectroscopy (FCS), and light scattering (LS) shown in 
Figure 12. All three techniques indicated hollow spheres with a diameter of around 200 nm 
with appropriate homogeneity (polydispersity index (PDI) = 0.2). The characteristic collapsed 
vesicle structures with a diameter of diameter of 200 nm are shown in Figure 12A. By 
extrapolating the data with Mie or Guinier plot (Figure 2C), we observed the radius of gyration 
(Rg) and radius of hydration (Rh) for all CNCs. CNC-linker-OmpF-M, CNC-OmpF-M and 
CNC-OmpF-WT were in a similar range of size with Rh of around 120 nm and Rg of 100-
110 nm, while CNC-noOmpF were slightly bigger (Rh = 138, Rg = 134 nm). The calculated 
ratios of Rh/Rg were found in the range between 0.8-1.0 presenting typical values for hollow 
spheres. 
Owing to the fluorescent side chains of the linker, the backbone binding of the linker to OmpF-
M has been assessed by FCS (Figure 12B). The autocorrelation curves revealed shifts in the 
diffusion times of linker-OmpF-M relative to free linker and linker-OmpF-M permeabilized 
CNCs relative to free linker-OmpF-M (Table S1). These characteristic increases in diffusion 
time confirmed a successful coupling of the linker to OmpF-M and a successful reconstitution 
of linker-OmpF-M in the polymeric membrane. In addition, we used brightness measurements 
to evaluate the number of linker molecules/OmpF pore.  With the counts per molecules given 
in Table S1, we calculated that one linker molecule is bound per OmpF-M monomer and 
obtained the average number of 9 reconstituted linker-OmpF-M molecules per CNC.  
We next assayed the in situ activity of encapsulated laccase in response to treating CNCs with 
NaIO4. Laccase is expected to catalyze the oxidation of 2,6-dimethoxyphenol (DMP) to the 
corresponding radical species. The resulting orange radical can be detected 
spectrophotometrically at 470 nm.212, 213 When DMP is added in the environment of CNCs, thus 
should diffuse through the OmpF pores to reach the enzyme, which is possible only when the 
linker-blocked OmpF-M pores are open as a result of the linker cleavage. The periodate-
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triggered unblocking of OmpF-M pores in CNCs was evaluated by measuring the absorbance 
related to DMP oxidation for several hours (Figure 13). As controls, we monitored the 
enzymatic activity of CNCs with linker-modified OmpF-M pores in the absence of NaIO4 
(CNC-linker-OmpF-M) and of corresponding CNCs without OmpF pores (CNC-no-OmpF). 
To establish whether NaIO4 cleaves the linker but does not affect the overall stability of the 
CNCs, CNC-no-OmpF was additionally treated with periodate (CNC-noOmpF-M with NaIO4). 
The quenching with glucose after periodate treatment avoided false positive signals from 
periodate-induced oxidation reactions. The treatment of CNC-linker-OmpF-M with NaIO4 led 
to a significantly higher absorbance at 470 nm as the DMP was able to diffuse into the cavity 
where it was oxidized to the colored product (Figure 3, pink curve). In the case of CNC-no-
OmpF, the periodate treatment neither induced oxidation of DMP, nor damaged the CNCs 
(Figure 13, yellow curve), which would have otherwise led to a release of laccase and to an 
enzyme-catalyzed oxidation of DMP. Our spectrophotometric results clearly indicate that the 
linker closes OmpF efficiently and second, enables a stimuli-responsive opening of OmpF-M 
pores in the presence of periodate. Additionally, the increasing absorbance demonstrated that 
periodate did not unhinge the activity of encapsulated laccase.  
Figure 13. Linker-based control of molecular passage through catalytic nanocompartments 
demonstrated by spectrophotometric assessment of laccase activity of CNCs in response to 
NaIO4 – The increase in absorbance at 470 nm reflects laccase-catalyzed substrate conversion. 
Measurements were carried out at RT for 9 h at pH = 7.4. NaIO4 cleaves the linker that blocks 
the passage of substrate through linker-OmpF-M pores in the closed state and thereby unblocks 
the pore. In the open state, DMP enters the compartment where it is oxidized in situ to a 
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detectable product by the confined laccase. The polymeric membrane separates the 
encapsulated laccase from the environment.  
 
We also measured the absorbance of CNCs over several days to evaluate how long the 
protection shield of polymersomes is protecting the encapsulated enzyme (Figure 14). The 
maximum activity of free laccase was reached after 8 h and continuously decreased over the 
following 12 h (Figure 14A). In contrast to this, enzymatic activity of laccase encapsulating 
CNCs whose membrane was permeable to DMP either by unmodified OmpF-M pores (CNC-
OmpF-M) or by periodate-induced opening linker-OmpF-M pores (CNC-linker-OmpF-M), 
increased for several days (Figure 14B). Again, in the absence of OmpF pores (CNC-no-OmpF 
with NaIO4), periodate treatment did not lead to the oxidation of DMP or damaged the CNCs 
as confirmed by TEM (Figure 14D). 
Figure 14. Long-term laccase activity of CNCs in response to NaIO4 (with standard deviation 
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calculated from three technical repeats), based on the increase in absorbance intensity of 
laccase-product with a characteristic absorbance at 470 nm – Measurements were carried out 
at RT at pH 7.4: A) Activity of free laccase in PBS solution (with standard deviation) recorded 
over 20 h; B) Activity measured for one week of i) free laccase in PBS solution (without 
periodate treatment (black)), ii) CNC-OmpF-M (without periodate treatment (orange)), iii) 
CNC-noOmpF-M (without periodate treatment (purple)), iv) CNC-linker-OmpF-M (without 
periodate treatment (yellow)), v) CNC-noOmpF-M (without periodate treatment (blue)) and vi) 
CNC-linker-OmpF-M with periodate treatment (pink); C) Schematic representation of the three 
different polymersomes with encapsulated laccase. D)  TEM micrographs of CNCs after 
periodate treatment. Scalebars: 500 nm. 
 
For comparison, we also tested laccase activity of corresponding CNCs using 2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulfonic acid diammonium salt (ABTS) as substrate (Figure S8). These 
enzyme assays involving CNCs were performed over several months, indicating that CNCs 
were active over long time periods if stored at 4 °C. However, DMP in PBS solution exhibited 
notable lower autooxidation212 over 9 h and thus was more suitable for our optimized long-term 
measurements of catalytic activity (Figure 14). Further evidence of the longevity of laccase 
encapsulating CNCs was provided by TEM micrographs recorded after eleven months 






Our CNC system allows the controlled activation of small catalysts and protects also sensitive 
catalysts from degradation by encapsulating them in stable polymeric nanocompartments. Due 
to i) efficient pore closing by a small organic linker and ii) due to precise pore-opening of the 
CNC by periodate, an improved spatio-temporal control has been achieved.  Secondly, the 
catalytic reactions are induced under mild conditions (no organic solvents, pH = 7, RT) where 
other sensitive biomolecules stay intact. Moreover, through the cleavage of the stimuli-
responsive linker, no modification to the CNC structure has been observed ensuring the full 
functionality of our system. Our approach in catalysis pave the way to a new molecular 
technology which might be extremely useful in multifunctional cluster activity when specific 
substrates or products need to be accessible at a precise time and space to be converted by the 
second catalyst to a desired molecule. We strongly believe that our novel approach for chemical 
OmpF modification with controllable functionality and improved properties could advance the 
development of sensitive catalysts based on CNCs for a broad range of applications including 
catalysis, food science and nanotechnology. For example, following titration experiments will 
provide more information regarding the sensitivity and selectivity of the linker towards 
periodate and will show if the CNCs are potential candidates as periodate sensors with 






THE PROMISING POTENTIAL OF GPMVS AS CELL-
MIMICKING PLATFORM 
 
Cellular model systems are essential platforms used across multiple research fields for 
exploring the fundaments of biology and biochemistry. Here, we present Giant Plasma 
Membrane Vesicles (GPMVs) as a platform of cell-like compartments that will facilitate the 
study of particles within a biorelevant environment and promote their further development. We 
studied how cellularly taken up nanoparticles (NPs) transfer into formed GPMVs and which 
are the molecular factors that play a role in successful transfer (size, concentration and surface 
charge along with three different cell lines: HepG2, HeLa, and Caco-2). We observed that, 
polystyrene (PS) carboxylated NPs with a size of 40 nm and 100 nm transferred successfully 
and efficiently into GPMVs derived from all cell lines. We then investigated the distribution of 
NPs inside formed GPMVs and established the average number of NPs/GPMVs and the 
percentage of all GPMVs with NPs in their cavity. Our results could  pave the way for GPMVs 
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Motivation and challenges ahead 
 
The history of GPMVs (Giant Plasma Membrane Vesicles) starts in the first half of the 20th 
century where the formation of cell surface “blebs” was observed after treating a chick embryo 
heart with a variety of hypotonic and hypertonic solutions.214 In 1948, the process of this 
formation, called potocytosis was described more accurately by using the phase microscope.215 
Later on, a method for isolating such plasma membrane vesicles (PMVs) from cells in higher 
amounts was developed. It was based on a great number of aldehydes and disulfide blocking 
agents that promoted the PMV formation and subsequent release from cells.184 This pioneering 
procedure replaced the traditional techniques for the isolation of cell surface membrane 
fragments and enabled targeted studies and applications of PMVs (nowadays called GPMV: 
Giant Plasma Membrane Vesicle). The followed reports of those newly discovered GPMVs 
focused on studying the compositional and structural characteristics of their plasma membrane 
after formation from different cell lines.181, 186, 216 Additionally, a detailed investigation of the 
properties of the membrane associated IgE-receptor complex was described.217 So far, the most 
investigated field of GPMV studies used the vesicles as an innovative platform with realistic 
biological membrane composition without the cytoskeletal constraint found in living 
cells.183,179, 218, 219 GPMVs are obtained directly from cells and include the cellular membrane 
and almost all cell components, except larger organelles, such as Golgi apparatus and the 
nucleus.181, 184 In addition to that, the known mechanism of GPMV formation involves local 
delamination of the cytoskeleton.185 Another research area also started dealing with the 
development and characterization of planar supported membranes received from GPMVs220, 221 
and exploited GPMVs as new tools for drug delivery.222 
Here, we introduce GPMVs as the novel type for a complete, overall cell-mimicking 
compartment. The complexity of cells encourages the development of a huge variety of 
simplified cell model platforms, of which the features can be tailored to the respective requested 
objective to fulfill different requirements, e.g. cell-like membrane compositions. Until now, 
cell-mimicking structures have become indispensable strategies for investigating highly 
complex biological processes such as molecule transport through cell membrane, or specific 
reactions controlled by enzymes in cell organelles.158  
With our study, we discovered a promsing new strategy of forming a new class of cell-
mimicking systems in order to overcome the current challenges of designing ideal cell-like 
compartments. Here, we propose as cell-mimicking compartments the GPMVs and studied how 
they can be equipped with nanoparticles (NPs) during their formation process such to provide 
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a cytoplasm medium in which the NPs freely move. We selected GPMVs as cell-like 
compartments because they combine the advantage of having both a cytoplasm and cell 
membrane185, 219 with a defined inner cavity volume and long-term stability without requiring 
cell cultivation. In addition, even though GPMVs are larger in size (in the lower µm range), 
their cell-identical composition supports them as promising platforms to study medically 
relevant exosomes. Cell-secreted exosomes are vesicles that contain plasma membrane 
proteins, cell-type-specific RNA and protein cargoes and play an important role in different 
biological processes such as intercellular signaling, stimulation or inactivation of T-cells.223  
Whilst exosomes attract a lot of attention with the focus on understanding different biological 
functions and on their applications in diagnostics and therapeutics, their development has 
stagnated due to their low production by cells and their inefficient isolation. In contrast to 
exosomes, GPMVs can be produced on a large scale, which turns them into valuable platforms 
in medical research.14 
While we previously proved that GPMVs can be equipped with soft nanoassemblies, such as 
liposomes and polymersomes14, here we go one step further and studied how hard NPs with 
different properties can transfer into GPMVs without affecting their properties and in which 
conditions this transfer can take place. We focused on different properties of NPs, such as 
surface chemistry, size and concentration that have the potential of influencing their transfer 
from cells into GPMVs.  We selected three cell lines in order to understand whether the transfer 
of NPs is mediated by the cell type and to identify which precursor cell line results in the largest 
GPMV population. By using fluorescent NPs, we evaluated qualitatively and quantitatively the 
number of NPs transferred into subsequently formed GPMVs as a function of the cell line by a 
combination of confocal laser scanning microscopy (CLSM) and flow cytometry. Our study 
reveals that a balance between the properties of the NPs and the cell line is crucial for obtaining 
a maximal loading of GPMVs. 
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Applying GPMVs as biomimicking platform 
 
In order to study the transfer efficiency of nanoparticles (NPs) from cells into the cavity of 
GPMVs, it is essential to investigate precisely all effects influencing the cellular uptake - size, 
concentration and surface of NPs. We selected carboxylated polystyrene (PS) NPs as those 
presents a suitable model system for determining the factors of particle functionalization.224 We 
studied the transfer of fluorescent NPs in sizes of 40 nm, 100 nm, 500 nm, that were added to 
the cells in different concentrations. Additionally, we studied how the surface modification of 
PS NPs could influence the cellular uptake and tested 100 nm sized particles functionalized 
with amine groups on the surface and NPs (100 nm) without any additional modification. The 
experiments were performed in parallel with three different cell types to investigate the cell-
dependent behavior of the endocytotic pathway. Within the endosomal transport of endocytosis, 
the taken up NPs (cargos) are delivered in endosomes. Here, a sorting process occurs where the 
cargos are routed to different organelles.  Cargoes can be sorted to recycling endosomal carriers 
bringing the cargos back to the plasma membrane.225 We assume that the cargoes found in the 
recycling process near the plasma membrane are exactly those NPs, we can observe inside 
GPMVs.   
HeLa cells were chosen for our experimental setup because of their role as model cell line for 
NP uptake studies.224 HepG2 cell line were selected due to their lack of membrane protein 
caveolae1 which disables the NP entry by caveolae-dependent endocytosis.226 As third cell line, 
we chose Caco-2 since they have been widely used as a model for the intestinal barrier. Due to 
its heterogenous structure, Caco-2 culture contains cells with slightly different properties. 227  
GPMVs are obtained directly from cells when they are exposed to chemical stress.228 All three 
chosen cell lines were able to form GPMVs when treated with a “vesiculation solution” 
containing reducing agent dithiothreitol (DTT) and cross-linking agent paraformaldehyde 
(PFA), however with varying sizes and uniformity. 
The cells have to uptake the respective NPs before the GPMV formation can be induced. By 
confocal laser scanning microscopy (CLSM) we investigated if these taken-up NPs have 
successfully been transferred into GPMVs and if they bear the potential for innovative tools in 
nanotechnology that retain the cell-like composition. The yielded GPMVs were observed by 
CLSM and we analyzed their average size by measuring the diameter of more than 250 GPMVs 




Evaluating a possible transfer of polystyrene nanoparticles with 
different surface modifications into GPMVs 
 
Polystyrene nanoparticles in cell medium 
In order to evaluate the nanoparticle (NP) transfer into GPMVs, it is important to investigate 
the NP properties influencing the cellular uptake: NP size, charge, surface chemistry and the in 
which concentration the particles were added to the cells.  
We first compared the impact of the NP’s surface properties. We selected i) PS NPs with 
carboxylate groups on the surface or ii) with amine groups instead and iii) PS NPs without 
additional surface modifications. All NPs had a size of 100 nm. Carboxylated NPs are known 
to be nontoxic and to be readily taken up by all cells at sizes smaller than 200 nm.224 Amine-
modified NPs were chosen as the natural occurring complement of the carboxylate group in 
amino acids. The unmodified NPs were used to understand the general influence of functional 
groups on the NP surface for the transfer into GPMVs. We ensured that the same conditions for 
all performed trials with any NPs were maintained so that we could compare the results of each 
experiment accurately. The initial concentrations of the NPs were determined by nanoparticle 
tracking analysis (NTA). Furthermore, the NPs were analyzed by dynamic light scattering 
(DLS) and zeta potential both in solutions of aqueous phosphate-buffered saline (PBS) and cell 
medium (Table 1) to visualize the resulting different hydrophobicity and hydrophilicity in these 
media. In contrast to PBS, cell medium contains high concentrations of proteins from fetal 
bovine serum.229, 230 
Table 1. Measurements of 100 nm PS particles with different surface modifications 
(carboxylated, aminated, unmodified) in PBS and cell medium. 
 
 
In cell medium, the NPs showed similar zeta potentials, stabilized to -8 mV and -10 mV.  
However, in PBS (pH 7.4) the carboxylated NPs and those without surface modifications were 
highly negatively charged; around -32 mV or more. The most extensive change in surface 




















145.8±1.0 -8.4±1.4 0.240±0.005 134.9±0.7 -8.2±0.8 0.299±0.023 136.3±0.6 -10.1±0.6 0.228±0.002 
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charge was observed in case of aminated NPs. While having a positive charge in PBS, these 
NPs turned slightly negative in cell medium (-8 mV).  
With regard to the size of NPs, we observed that the hydrodynamic radius all NPs was higher 
in cell medium (30-38 nm) than in PBS. In cell medium, the implied proteins adsorbed onto the 
NPs surface and formed a protein corona which induced in a bigger measured particle size, 
higher polydispersity index (PDI, Table 1) and change in zeta potential.231 In case of the three 
different NPs, all zeta potentials shifted more towards zero while the hydrodynamic diameter 
increased slightly of ca. 36-38 nm. In general, the effect of a protein corona depends on its 
protein composition and the resulting strength of adsorption forces between the proteins and 
NP surface.232-234 As a strong surface charge prevents NPs from aggregation, further 
characterization by transmission electron microscopy (TEM) of NPs in cell medium was 
essential to prove that no aggregations occurred in the medium (Figure 15) that could distort 
the performed DLS measurements or manipulate the following cellular uptake studies. 
 
 
Figure 15. TEM micrographs of carboxylated, aminated and unmodified NPs in cell medium 
– Scale bar of top images: 500 nm and for images below: 200 nm. 
 
Effect of the surface modifications of PS NPs on their transfer into GPMVs 
For studying the impact of the NP’s surface properties on the transfer into GPMVs, we treated 
three cell lines (HepG2, Caco-2 and HeLa) with different fluorescent PS NPs (carboxylated, 
aminated, without additional surface modifications) having a size of 100 nm.  In the first step, 
the cells were incubated for 24 h with the selected NPs to induce the uptake. Then, the GPMV 
formation was promoted by treating the cells with a solution containing PFA and DTT 
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(vesiculation buffer). After 1-2 h, the GPMVs were isolated from cells by centrifugation 
(Figure 16). 
By LSM, we investigated if the fluorescent NPs are located in the formed GPMVs. By 
comparing the NPs with different surface modification, we observed that only carboxylated 
NPS transferred from cells into GPMVs (Figure S14). Both the aminated NPs and those without 
additional functional groups were not found in GPMVs formed from any cell line. Moreover, 
Caco-2 cells especially, underwent serous changes in the morphology indicative for cell death 
after incubation with aminated NPs. At the highest concentration it was not possible any more 
to yield GPMVs from the treated cells. Regarding aminated NPs, it is known that a positive 
surface charge can increase the uptake as the resulting interaction with the negatively charged 
cell membrane is stronger. However, on the other hand previously published studies reported 
toxic effects towards cells caused by aminated NPs which is also in agreement with our 
observations where the irregular cellular morphology suggested to cell damages. Positively 
charged NPs having amine or cysteamine groups on the surface induced destabilization of the 
lysosomal membrane and damaged the mitochondria after entering the astrocytoma cell line 
1321N1.230 For endothelial cells, a positively charged NP surface led to a strong reduction in 
cell viability, whereas neutral and negatively charged nanoparticles were classified as highly 
biocompatible.229 In addition, it had to be considered that the stability of the protein corona 
verified by DLS (Table 1) depended highly on adsorption forces between the surface charge of 
the NPs and the protein source. As a consequence, the individual charge of the functional groups 
on NPs still had to be taken into account during cellular uptake233. 
 
 
Figure 16. General procedure for generating GPMVs from cells loaded with NPs – A) NPs 
are taken up by the cells within 24 h. B) NPs  transfer into GPMVs during GPMV formation, 
induced by GPMV vesiculation solution. C) After 1-2 h the NP equipped GPMVs are formed 
and isolated from the cells. 
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By comparing the two negatively charged NPs (carboxylated, unmodified) we investigated that 
not only the surface chemistry but also the biocompatibility of the NPs played a crucial role in 
the transfer process from cells into GPMVs. The carboxylated NPs have been often used for 
cell uptake studies as they are known to be nontoxic are known for their biocompatibility.224 In 
contrast to this, the unmodified NPs were not found in GPMVs although these NPs also had a 
strong negatively charged surface.  
The experiments demonstrated how strong the surface chemistry and biocompatibility affected 
the NP transfer into GPMVs. Positively charged aminated NPs induced an intrinsic cytotoxic 
effect on the cells, and simultaneously prevented their transfer signaling that such 
nanostructures are not biologically relevant for future biomedical studies. In general, the uptake 
of NPs by cells without causing cell death so that GPMVs can still be formed, was the 
fundamental precondition for a successful NP transfer into GPMVs. In contrast to synthetic 
GUVs, this kind of built-in sorting out system of not biocompatible nanomaterials occurred 
naturally in the case of GPMVs and presents a direct advantage over GUVs, where all kinds of 
nanoscale objects can be encapsulated with no feedback information on biorelevance.13, 140 This 
described biocompatible-selectivity of GPMVs allowed the application as cell-mimicking 
platform while maintaining a strong resemblance to real cells. 
As the carboxylated NPs were both non-toxic and successfully taken up and transferred into 
GPMVs, we selected them to establish the role of other molecular properties on the NPs transfer 
into GPMVs. We focused on the questions such as how different sizes and concentrations of 





Crucial preconditions for the transfer of polystyrene carboxylated 
nanoparticles into GPMVs 
 
Analysis of empty GPMVs by CLSM 
In order to investigate if the transfer process of NPs into GPMVs has an impact on the size of 
the formed GPMVs, we first evaluated the average size of 250 GPMVs from each cell line 
(HepG2, Caco-2, HeLa) without NPs (Figure 17). The yielded GPMVs were isolated from the 
cells and observed by confocal laser scanning microscopy (CLSM) to measure the respective 
diamters of the GPMVs. HepG2 produced GPMVs in a range of ca. 5-14 µm. Caco-2 cells 
formed the biggest GPMVs on average with a size and with a large size distribution between 6 
and 20 µm. The smallest, yet most uniform in size, GPMVs were obtained from HeLa cells (4-
8 µm).  
 
 
Figure 17. HepG2, Caco-2 and HeLa cells form GPMVs – A) HepG2 cells after GPMV 
formation, B) Caco-2 cells after GPMV formation, C) HeLa cells after GPMV formation, D) 
average size of GPMVs generated by HepG2 (red), Caco-2 (blue) and HeLa cells (green) given 
as average diameter in µm with standard deviation. Significance level: p < 0.5 (*). 
 
Effect of size and cellular uptake of carboxylated PS NPs on transfer into GPMVs 
In the subsequent study, we determined an upper size limit of carboxylated NPs that still 
transferred into GPMVs using red fluorescent carboxylated PS NPs with different sizes (40 nm 
and 100 nm (Figure S15) and 500 nm (Figure S16)). The original concentrations of the particle 
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suspensions were analyzed by NTA (Table S3) to prepare dilutions at the same NP 
concentration (4´109 particles/mL, 8´109 particles/mL, 1.6´1010 particles/mL). First, the three 
cell lines (HepG2, Caco-2, HeLa) were treated with 500 nm particles to determine the upper 
limit of NP transfer. The resulting CLSM images showed only empty GPMVs after isolation 
from the cells indicating that particles of 500 nm in size were already above the maximum size 
limit for transferring NPs into GPMVs (Figure S16). In contrast to 500 nm particles, NPs of 
40 nm and 100 nm in size were observed in the GPMVs formed by all three cell lines 
(Figure S15).  
As mentioned above, the cellular uptake of the nanostructures into cells presented one important 
checkpoint in the investigation of the GPMV platforms. Therefore, the NP cell uptake was a 
crucial step we had to consider when optimizing the transfer of different particles into GPMVs. 
Due to this, flow cytometry analysis with each cell line treated with 40 nm or 100 nm 
carboxylated PS NPs at three different concentrations were performed (4´109 particles/mL - 
1.6´1010 particles/mL, Figure S17-S20). In general, we observed a dose dependent increase in 
NP uptake in the case of all three cell lines. Regarding the selectivity, we observed that all cell 
lines favored the uptake of the smaller 40 nm NP over the larger 100 nm particles where 
significantly more 40 nm particles have been taken up at most tested concentrations compared 
to 100 nm NPs. The selectivity towards the different sizes was only negligible at the highest 
NP concentration tested (1.6´1010 particles/mL) for HepG2 cells and at the lowest NP 
concentration (4´109 particles/mL) tested for Caco-2 cells.  
The results will serve as a basis for determining the relationship between uptake and transfer of 
the NPs into GPMVs.  
  
Analysis of isolated GPMVs with transferred NPs by flow cytometry and CLSM 
After determining that the three cell types have efficiently taken up the NPs in a concentration 
dependent manner, we turned the focus towards investigating the appropriate technique for 
analyzing GPMVs as biomimicking platform. We started with a combination of both flow 
cytometry and CLSM to examine which method provided the most valuable information about 
the formed GPMVs and about the transferred NPs for a detailed analysis.  The focus of this 
experiments was to clarify which of the two technique (flow cytometry or CLSM) provided the 
most appropriate analysis for the investigation of NP transfer into GPMVs. Based on the 
success with isolating GPMVs from HepG2 cell line in a previous study14, we chose HepG2 as 
a model cell line to determine first if GPMVs are detected adequately by these two different 
measurement techniques and second, to identify and evaluate the information that were 
 61 
provided by these two techniques. Therefore, we treated the HepG2 cells with different 
concentrations of 100 nm red fluorescent carboxylated PS particles (4´109 particles/mL, 8´109 
particles/mL and 1.6´1010 particles/mL) in order to evaluate the dose-dependent NP transfer by 
flow cytometry and CLSM. 
 
 
Figure 18. Flow cytometry measurements of isolated GPMVs formed from HepG2 cells and 
loaded with increasing concentrations of 100 nm red fluorescent carboxylated PS NPs – A) 
three technical repeats of the  measurements. The graphs of three self-standing flow cytometry 
measurements include the following peaks for GPMVs yielded from cells incubated with:  REF 
no NPs (grey), 1: 4´109 particles/mL (blue), 2: 8´109 particles/mL (green), 3: 1.6´1010 
particles/mL (red). B) Flow cytometry analysis of GPMV size characterization by sideward and 
forward scattering analysis. The marked-out section represents GPMV populations used for 
analysis by flow cytometry. 
 
Flow cytometry analysis allowed a fast determination of the amount of GPMVs derived from 
HepG2. In addition, flow cytometry provided an analysis of the fluorescence of NP-equipped 
GPMVs, where we observed the effect of the NP concentration on the NP transfer ratio into 
GPMVs (Figure 18). Empty GPMVs served as a negative control (red peak) and the 
measurement series were repeated three times.  The measurements showed clear the expected 
dose dependent increase in the NP loaded GPMV population. At the highest NP concentration, 
more than half of all GPMVs were loaded with NPs. 
The visualization of the GPMVs from HepG2 by CLSM allowed us to track the red-fluorescent 
NPs inside all GPMVs. The NPs diffused freely inside the cytoplasm of the GPMVs. In contrast 
to flow cytometry, CLSM provided information about the size of each GPMV and about the 
distribution of transferred NPs and the average number of NPs/GPMV together with the mean 
size of the respective GPMVs (Figure S21-S26). Furthermore, we were able to distinguish by 
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CLSM if NPs are inside GPMVs or if interactions or aggregation between NPs and the 
membrane occurred.  
As a result, we chose CLSM as the main imaging technique to establish and quantify the impact 
of size and concentration on the NP transfer process from three different cells (HepG2, Caco-
2, HeLa) into GPMVs, since it allowed an exact localization of NPs. With CLSM it was possible 
to guarantee that only NPs freely diffusing within the cavity of the GPMVs were taken into the 
study without aggregation present or high affinity toward the GPMV membrane (Figure 19).   
 
Figure 19. GPMVs isolated from HepG2 cells – The membrane was stained fluorescent green 
either by A) CellMaskTM or B) Lck-GFP-transfection14. Inside GPMVs, red fluorescent 
carboxylated PS NPs (100 nm) can be observed. 
 
Effect of initial concentration of carboxylated PS NPs (40 nm, 100 nm) on their transfer 
to GPMVs 
We treated the three cell lines with 40 nm and 100 nm fluorescent carboxylated NPs particles 
in increasing concentrations (4´109 particles/mL, 8´109 particles/mL, 1.6´1010 particles/mL, 
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and 1.6´1011 particles/mL) to quantify the impact of NP concentration on the transfer 
efficiency. After incubating the cells with NPs and subsequent GPMV formation, the transfer 
of 40 nm and 100 nm particles into GPMVs was visualized by CLSM (Figure S27 and 
Figure S28). We imaged more than 250 GPMVs in each experiment and summarized the 
observations regarding the average numbers of NPs/GPMV (Figure 20) and the percentage of 
GPMVs that showed NPs in the cavity as function of NP size and concentration GPMVs 
(Figure 21). One experiment covered the analysis of isolated GPMVs derived from one of the 
three cell lines treated with one type of NP size at each concentration, where we determined the 
number of NPs/GPMV along with the diameter of GPMVs using ImageJ. By collecting and 
summarizing all data, we received distribution graphs (Figure S21-S26), showing the diameter 
of GPMVs on the x-axis and the number of NPs inside GPMV on the y-axis. We investigated 
that the size of formed GPMVs has not been affected by the transfer process of NPs for any of 
the three cell lines, which further supported GPMVs as a platform to study NPs in a cell-like 
environment. In case of HepG2 cells, the formed GPMVs had a size of 8.7±4.1 µm in the 
absence of NP uptake (Figure 17). The average size of GPMVs equipped with 40 nm sized NPs 
was 7.3±0.6 µm and 7.3±0.2 µm when equipped with 100 nm sized NPs. These results 
demonstrated that neither the transfer of NPs nor their size up to 100 nm affected the mean 
value of the diameter of GPMVs if NPs have transferred into the cavity.  
For Caco-2 and HeLa cells, an impact of the NP transfer on the diameter was slightly more 
pronounced but still not significant. GPMVs formed by Caco-2 cells, showed an average size 
of 13.1±6.9 µm in absence of NPs, while the 40 nm particle transfer resulted in GPMVs with a 
diameter of 7.9±0.4 µm and 10.0±0.8 µm for 100 nm. In case of HeLa cells, we obtained 
slightly bigger GPMVs if there were no NPs inside (6.2±2.2 µm) and when equipped with 
40 nm particles the mean size of GPMVs decreased to 3.9±0.4 mm, and 5.8±0.6 µm for transfer 
of 100 nm NPs. Summarizing all data, we suggest that the transfer of NPs into GPMVs for 
Caco-2 and HeLa preserved the order of magnitude of the GPMVs size, but in contrast to 
HepG2, a higher degree of size change was observed. 
With regard to the average number of NPs/GPMV (Figure 20), we observed that each cell line 
had a different average number of 40 nm and 100 nm particles per GPMV. For these 
experiments, the determined NPs represented the minimal number of NPs/GPMVs as the 
number was obtained by CLSM micrographs without a 3D staking. The NPs were freely 
moving inside GPMVs, so each micrograph presented a current snapshot of the NPs in the 




Figure 20.  Average number of 40 nm (yellow) and 100 nm (green) NPs in 1 GPMV – GPMVs 
were obtained from three cell lines HepG2, Caco-2 and HeLa. NPs were used at 4 different 
concentrations: 4´109 particles/mL, 8´109 particles/mL, 1.6´1010 particles/mL, and 1.6´1011 
particles/mL. 250 GPMVs/cell line and for each type of NPs were observed by CLSM. Error 
bars are given as ± standard deviation, significance level: p < 0.5 (*). 
 
Considering the size of NPs, we observed the highest difference of the average number of 
NPs/GPMV for the Caco-2 cells. At the maximum concentrations of the NPs, a number of 
3.2±0.3 particles/GPMV was reached for 40 nm, and 1.3±0.2 particle/GPMV were obtained for 
100 nm particles. In contrast to Caco-2, HepG2 and HeLa cell lines did not show a considerable 
effect of the NP size on the average number of NPs/GPMV. In GPMVs formed from HepG2, 
the number of 40 nm particles found per GPMV at highest concentration was 1.9±0.2, and 
2.8±0.3 particles/GPMV in case of 100 nm. For HeLa cells, the average numbers of NPs were 
1.5±0.2 (40 nm NPs) and 1.8±0.3 (100 nm NPs) per GPMV.  
Even though it is possible to achieve a higher efficiency of NP encapsulation by microfluidic 
assembly, such resulting GUVs cannot keep up with the huge cell resemblance of GPMVs. For 
our study it was important to select GPMVs instead of GUVs as cell-mimicking platform since 
GPMVs contain both a cytoplasm and cell membrane. In comparison with NPs encapsulated in 
GUVs performing controlled reactions inside GPMVs140, the average number of 1-3 NPs per 
GPMV presented a sufficient number of a successful nanoobject transfer with the future 
potential of mimicking cellular signaling pathways. As mentioned above, the numbers 
summarized in the graph, were maybe lower than the real numbers. Our counted values were 
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obtained by observing single plane projections of GPMVs, but the NPs were freely moving 
inside GPMVs. Besides that, there was no correlation between the number of NPs/GPMV and 
the size of GPMVs. 
The percentage of GPMVs from each cell line that contained transferred NPs (loaded GPMVs) 
is shown as total numbers in Figure 21. In the case of HepG2 cells, the percentage of loaded 
GPMVs increased with the concentration of NPs which was also in in agreement with the above 
presented flow cytometry measurements suggesting that the percentage of cellularly taken up 
NPs correlated with the initial concentration used for cell incubation. The calculated values 
derived from recorded CLSM images (Figure 21), showed that by treating HepG2 cells with 
the highest NP concentration (1.6´1011 particles/mL), the number of formed GPMVs with NPs 
inside increased to 40-43 %. The percentage of the loaded GPMVs from HeLa cells exhibited 
a similar dependency on the NP concentration as compared to HepG2 cells. But in contrast to 
HepG2, the maximum percentage was lower: 20 % of the GPMVs were equipped with 40 nm, 
and 14 % with 100 nm particles. In case of Caco-2 cells, the number of resulting loaded GPMVs 
depended notably on the size of the transferred NPs. 35 % loaded GPMV population was 
achieved for the 40 nm NPs, but only 25 % for the 100 nm particles. In summary, the transfer 
efficiency of NPs was the greatest when transferring from HepG2 cells into the subsequently 
formed GPMVs. Here, almost 40 % of the GPMVs were successfully loaded in case of 40 nm 
particles at highest concentration, and 45 % in the case of 100 nm particles. In total, HeLa cells 
had the lowest transfer of the three cell lines with only 15-20 % loaded GPMVs at the highest 
concentration of NPs. 
Comparing the cellular uptake studies of NPs in individual cell lines (Figure S17-S20) to the 
results of NP loaded GPMVs (average number of NP/GPMV and % of NP loaded GPMVs) we 
assumed that the NP to GPMV transfer was not only promoted by an efficient cell uptake. 
Addditionally, it depended on the “post-GPMV-behavior” of each cell-type. For example, while 
the uptake of 40 nm NPs was favored for HepG2 cells, we observed, however, that the transfer 
of 100 nm NPs from HepG2 into GPMVs was more favored. In case of Caco-2, 40 nm NPs 
were favored both in the cellular uptake of the NPs and in the NP transfer process into GPMVs. 
HeLa cells seemed to be not be as selective towards NP size. This indicated that for designing 
a GPMV platform, both first step (cellular uptake) and the transfer and isolation as second step 
were crucial. Again, this highlighted the advantage of a designed GPMV platform over 
synthetic or lipidic GUVs.  In GPMVs, only biocompatible nanostructures, that were readily 




Figure 21. Percentage of all GPMVs equipped with 40 nm (red) or 100 nm (blue) NPs in 
their cavity. – GPMVs were obtained from three cell lines HepG2, Caco-2, HeLa. NPs were 
used at four different concentrations: 4´109 particles/mL, 8´109 particles/mL, 1.6´1010 
particles/mL, and 1.6´1011 particles/mL. 250 GPMVs/cell line for each type of NPs were 
observed by CLSM. 
 
Considering our results about the effect of concentration and size of carboxylated PS NPs, we 
were able to extract interesting characteristics for each cell line. The GPMVs formed from 
HepG2 and HeLa cells seemed to be dependent on the NP concentration, but independent on 
the size of the NPs as the transfer of 40 nm and 100 nm showed similar results regarding the 
average number of NPs/GPMV and percentage of NP-loaded GPMVs. In contrast to this, Caco-
2 cells resulted in a more size dependent transfer of the NPs. Compared to 100 nm particles, 
the treatments with 40 nm particles achieved considerably higher values of the average number 





GPMVs present an innovative alternative to synthetic GUVs in applications as a biomimicking 
platform. GPMVs have a high potential for many different biologically relevant studies and are 
assumed to present the closest cell mimics. Our study highlighted their further medical 
potential. However, the lack of information regarding loading strategies with nanostructures 
limited the further development of GPMVs considering the multifaceted details of the NP 
transfer mechanisms. Additionally, the impacts of the respective cell line are complex and still 
not investigated completely. Therefore, our work aimed to start the investigation how the 
transfer on NPs into GPMVs could be optimized regarding different properties of  NPs in order 
to designed cell-mimicking platforms that benefit from a cytoplasm medium and a cell 
membrane as boundary.  
By comparing HepG2 and Caco-2 cells with HeLa as the model cell line for carboxylated PS 
NP uptake studies, we demonstrated that the NP transfer mechanism form the cells into GPMVs 
was cell dependent. With focus on the size of GPMVs, HeLa cells formed smaller but more 
uniform GPMVs while Caco-2 cells yielded larger GPMVs but having a bigger size 
distribution. The results regarding HepG2 cells having a lack of the membrane protein 
caveolae1, we observed that HepG2 are particularly well suited for GPMV formation, as the 
cells showed a high abundance of NP loaded GPMVs with no observable effect on the size of 
the GPMVs. HepG2 cells resulted GPMVs with a high average number of 40 nm and 100 nm 
particle loaded GPMVs. Caco-2 cells, already known for great adsorption skills (model for the 
intestinal barrier) seemed to be the best choice for 40 nm NPs, especially, since here the 
obtained average number of NPs/GPMV was the highest compared to HepG2 or HeLa.  
In general, we suggest that a balance between the highest NP concentration (achieving the most 
efficient transfer of NPs into GPMVs) and the NPs’ intrinsic toxicity is essentail. For optimizing 
GPMVs as cell-mimicking platform, we want to highlight the fact that biocompatibility of the 
nanostructures was already taken into account during the tranfer process as it was an important 
prerequisite for our system. Compared to synthetic GUVs, we have the possibility to prescreen 
all non-biorelevant nanostructures prior to loading in case of designing GPMVs as 
biomimicking platform. Therefore, GPMVs allowed us to study only nanostructures with high 
biomedical potential. We are convinced that our study provided an important guideline towards 
further modification and applications for GPMVs equipped with nanoassemblies. GPMVs 
allowed us to study the interactions of NPs or investigate distinct reactions of 
nanocompartments inside a close-to nature system. Our study will help promote the future 
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development of GPMVs such as an optimized strategy to separate modified GPMVs from non-
modified. Potential approaches may include a technique resembling to FACS (Fluorescence 






CLOSING REMARKS AND OUTLOOK 
 
Polymersomes allowing the modification with diverse biomolecules and compounds are 
described detailed in this work. Such bioactive nanocompartments have increasing potential in 
many different applications as their versatility is markedly expanded by the biomolecules that 
endow the polymersomes with specific molecular and cellular functions. In particular, 
polymersomes are of great interest because of the increased stability and biocompatibility. 
Towards the development of bioactive polymersomes, we modified chemically OmpF as a 
biopore that showed triggerable permeability when reconstituted in the polymeric membrane. 
For the OmpF modification, we designed and synthetized a small organic linker that blocked 
the passage of molecules through the pore. In presence of periodate, the linker was cleaved and 
the diffusion through OmpF was established. Inside the polymersomes, laccase was 
encapsulated to catalyze the oxidation of an external substrate to a colored product and to 
visualize the pore opening. For closing the pore and for a controlled cleavage, different factors 
had to be taken into account during the linker design. The linker was designed to have the 
appropriate size to block the OmpF passage and at the same time to allow the anchoring of 
different functional groups. The linker was equipped with maleimide ends to enable the 
covalent binding to two engineered cysteine of OmpF (OmpF-M). In the middle of the linker 
structure, we needed a functional group where covalent bonds cleave upon a certain stimulus 
(periodate). In addition to this, we modified the linker with fluorophores to facilitate the 
detection and consequent measurements. For the synthesis of the linker, we used peptide 
crosslinkers commonly used for bioconjugation as starting materials. Such crosslinkers allowed 
mild reaction conditions and formed products with expected water solubility. In general, it is 
essential to work in aqueous solutions during the protein modification to prevent the protein 
structure and functionality. Furthermore, we applied organic chemistry techniques for high 
reaction yields and purifications. Our approach to the chemical modification of membrane 
proteins presents a first step towards the development of biomolecules with triggerable 
functionality and activity due to the guaranteed mild working conditions. A promising future 
study regarding the linker would be to investigate if after the oxidation (clevage of the linker) 
a subsequent reduction will merge the two linker residues together again. This would show the 
potential of the linker as a reversible blocking/unblocking tool of the OmpF pore. Another 
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chemistry-related protein modification could describe a synthesis of a linker that allows 
reversible activation without breaking chemical bonds and provides mild conditions. An 
advanced linker structure would be needed that e.g., undergoes different reversible spatial 
orientations leading to a blocking/unblocking of a membrane protein or activation/deactivation 
of a receptor. One opportunity would be light-sensitive compounds such as azobenzenes that 
changes from trans to cis conformation upon a certain wavelength. 
In addition to synthetic biomimicking compartments, like GUVs, GPMVs represent an 
innovative platform for cell-mimics as such microscale compartments are derived formed from 
cells and include most of the cellular components (e.g., biological membrane and cytoplasm). 
Moreover, GPMVs can be produced fast and isolated in larger quantities by chemical treatment. 
Even though GPMVs are the closest cell-like compartments available on the market, the 
application of GPMVs as cell-mimicking platform in biological relevant studies remains a 
challenge.In our second study, we demonstrated that GPMVs were formed from different cell 
lines. Depending on the cell line, GPMVs have a size from 4 to 20 µm. By investigating the 
transfer of cellular taken up NPs into subsequent formed GPMVs, we were able to gather new 
insides and trends regarding the customizable modification of GPMVs with synthetic nanoscale 
objects. We studied the impact of different cell lines and NPs varying from surface 
modification, size and concentration on the NP transfer process. An interesting next step in this 
field would be the investigation of GPMVs as promising alternatives towards exosomes. As 
both platforms are directly formed from cells, they show similar compositions, but in contrast 
to exosomes, GPMV production and modification is more practicable and faster. Therefore, it 
would be very interesting to decrease the size of GPMVs in the nanoscale (more similar to 
exosomes) and investigate properties of GPMVs especially regarding targeted drug delivery 










Disuccinimidyl tartrate (DST) and 3,3'-N-[ε-maleimidocaproic acid] hydrazide, trifluoroacetic 
acid salt EMCH were purchased from ThermoFisher, cyanine 3 maleimide from Lumiprobe. 
All other materials were purchased from Sigma Aldrich, except the PMOXA11-b-PDMS104-b-
PMOXA11 triblock copolymer which was previously synthesized in our group. All reagents 
were of the highest commercially available grade and were used without any further 
purification, unless stated otherwise. 
 
Methods 
Synthesis of amphiphilic triblock copolymer  
The amphiphilic block copolymer PMOXA11-b-PDMS104-b-PMOXA11 was previously 
synthesized in our group according to reported protocols.59, 93 Briefly, a hydroxyl-terminated 
bifunctional PDMS was reacted below -10 °C with trifluoromethanesulfonic anhydride in dry 
hexane, leading to the activated PDMS macroinitiator. After filtration under argon and removal 
of hexane under vacuum, dry chloroform was added as reaction solvent, in which dry 2-methyl-
2-oxazoline (MOXA) reacted with the macroinitiator via symmetric cationic ring-opening 
polymerization. The hydroxyl-terminated triblock copolymer was obtained after quenching the 
polymerization reaction with a triethylamine/water mixture (1:4 v/v) and ultrafiltration in a 1:5 
(v/v) water/ethanol mixture. A number-average molecular weight (Mn) of 8700 g mol-1 and a 
chemical composition of PMOXA12-b-PDMS87-b-PMOXA12 was obtained from the 1H-NMR 
spectrum of this triblock copolymer, whereas its dispersity (Ð) of 1.6 was revealed by gel 
permeation chromatography (GPC) in THF.59 To decrease the dispersity of this copolymer and 
thereby better control the shape morphology of the self-assembled structures, an extraction from 
a1:1 (v/v) hexane/methanol mixture was performed and the copolymer fraction with a longer 
PDMS block was recovered from the hexane phase after solvent removal. After this additional 
step, the copolymer with a longer PDMS block was characterized by 1H NMR (Figure S6) and 
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SEC (Figure S7), obtaining the final chemical structure as PMOXA11-b-PDMS104-b-PMOXA11 
with Mn = 9800 g mol−1 (from 1H-NMR) and Đ = 1.23 (from SEC). 
1H NMR (500 MHz, CDCl3) δ/ppm = 3.84 – 3.15 (bm, 8H), 2.30 – 1.96 (bm, 6H), 1.64 – 1. 53 
(bm, 4H), 1.38 – 1.26 (bm, 4H), 0.50 – 0.60 (m, 4H), 0.20 – -0.10 (bs, 6H). 
 
Synthesis and characterization of the bismaleimide Linker 
To obtain the thiol-reactive linker able to covalently bind to both thiol groups of the OmpF 
double mutant and block its pore, we have selected as diol-containing starting compound the 
disuccinimidyl-activated derivative of tartaric acid. Thus, Compound 1 was first synthetized 
according to a general procedure used for crosslinking proteins with small modifications.235 
Briefly, disuccinimidyl tartrate (DST, 10.7 mg, 31 mmol, 1.0 eq.) was first dissolved in 100 µL 
DMSO in an Eppendorf tube (1.5 mL), and then a 0.24 M aqueous solution containing L-
cysteine was added (284 µL, 68.2 mmol, 2.2 eq.). After the pH was adjusted to a value between 
8 and 9 with 1 M NaOH (aqueous solution), the reaction mixture was shaken in the dark at RT 
for 16 h. The resulting suspension was centrifuged (13.400 rpm, 5 min). The solvenst were 
removed by rotary evaporator, and the resulting product was dried under vacuum for 3 days to 
give Compound 1 as a white solid which was further used in the synthesis of Compound 2. 
MF: C10H16N2O8S2  
MW: 356.36 
ESI-MS m/z calcd for C10H16N2O8S2 [M+2H]+: 179.02; found: 179.05. 
1H-NMR (D2O, 500 MHz): δ = 4.68 (d,), 4.65 ppm (d), 3.45-3.30 (dd, 4H) ppm. 
13C-NMR (D2O, 126 MHz): δ = 176.49, 173.51, 162.97 (d, J = 35.5 Hz), 72.45, 72.35 (d, J = 
7.0 Hz), 54.87, 53.49, 38.72, 37.55, 25.17 ppm. 
The synthesis of Compound 2 was adapted and modified from literature.236 Compound 1 
(2.8 mg, 8.0 mmol, 1.0 eq.) was dissolved in 200 µL mixture of H2O/DMF = 1/1 with a pH>8, 
whereas cyanine 3 maleimide (10.7 mg, 16.0 mmol, 2.0 eq.) was dissolved in 400 µL DMF. 
Both solutions were combined, and the resulting reaction mixture was shaken in the dark at RT 
for 16 h after adjusting the pH value back to 8 with 1 M NaOH. The solvent mixture was 
removed by adding an excess of toluene and subsequent rotary evaporation. To the crude 
product 10 mL H2O with a pH>8 was added. The aqueous layer was extracted 3x with DCM. 
The organic phases were collected, and the solvent was evaporated to give Compound 2 as 















MF (cation): C80H104N10O14S2  
MW: 1515.87 (cation),  
ESI-MS m/z calcd for C82H102N10O14S2 [M+2H]+: 
379.18; found: 379.16. 
1H-NMR (500 MHz, CDCl3): δ = 11.35 (s, 2H), 8.38 (t, 
J = 13.4 Hz, 2H), 7.45 – 7.32 (m, 9H), 7.17 (d, J = 8.0 
Hz, 2H), 7.12 (d, J = 8.0 Hz, 2H), 6.70 (t, J = 13.9 Hz, 4H), 6.41 (d, J = 13.1 Hz, 2H), 5.82 (d, 
J = 13.1 Hz, 2H), 4.17 (t, J = 7.6 Hz, 4H), 3.69 (s, 6H), 3.52 – 3.39 (m, 7H), 2.30 (t, J = 6.8 Hz, 
4H), 2.23 (d, J = 10.4 Hz, 8H), 1.84 (p, J = 7.8 Hz, 4H), 1.80 – 1.75 (m, 4H), 1.72 (d, J = 5.5 
Hz, 22H), 1.56 – 1.41 (m, 4H). 
13C-NMR (126 MHz, CDCl3): δ =174.73, 174.57, 174.04, 171.47, 168.05, 151.03, 143.03, 
142.15, 140.97, 140.69, 138.71, 129.47, 129.34, 128.15, 126.04, 125.79, 122.43, 122.40, 
111.80, 111.10, 104.46, 104.18, 77.67, 77.41, 77.16, 49.61, 49.32, 44.84, 39.84, 39.47, 36.74, 
31.88, 28.50, 27.47, 26.05, 25.53. 
 
The Linker was synthetized according to the general procedure used for chemical labelling 
with small modifications.237 Briefly, 3,3'-N-[ε-Maleimidocaproic acid] hydrazide, 
trifluoroacetic acid salt (EMCH, 4.2 mg, 12.3 mmol, 2.5 eq.) was dissolved in 300 µL H2O, 
whereas 1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC HCl, 4.7 mg, 24.5 mmol, 
5 eq) in 100 µL H2O. A solution of Compound 2 (7.6 mg, 4.9 mmol, 1 eq.) was prepared in 
H2O/DMF (1:1000, 3 mL). All three solutions were combined, and the pH was adjusted to 7 
with 1 M NaOH. The reaction mixture was stirred in the dark at RT for 16 h. The crude product 
was purified by extraction with DCM (3x). The organic layers were combined, and the solvents 
were evaporated to yield the Linker as pink solid (8.0 mg, 3.8 mmol, 78 %). 
MF (cation): C102H128N16O18S2  
MW (cation): 1930.36 
ESI-MS m/z calcd for C102H128N16O18S2 [M+H]+: 643.64; 
found: 643.68. 
1H-NMR (500 MHz, CDCl3): δ 7.71 (d, J = 16.0 Hz, 1H), 
7.58 – 7.49 (m, 3H), 7.46 – 7.30 (m, 9H), 6.87 – 6.67 (m, 
2H), 6.46 (d, J = 16.0 Hz, 2H), 6.15 (t, J = 1.3 Hz, 2H), 5.62 
– 5.53 (m, 1H), 5.29 (s, 9H), 4.51 – 4.39 (m, 6H), 4.22 – 































































(m, 4H), 1.99 – 1.85 (m, 15H), 1.72 (d, J = 5.9 Hz, 16H), 1.41 (s, 3H), 1.32 – 1.17 (m, 13H), 
1.10 (s, 8H), 0.90 – 0.79 (m, 3H), 0.07 (s, 1H). 
13C-NMR (126 MHz, CDCl3): δ 167.20, 166.71, 145.43, 135.96, 134.29, 130.45, 128.94, 
128.93, 128.16, 126.11, 117.54, 77.24, 62.52, 62.21, 59.53, 53.44, 38.15, 31.24, 29.71, 28.13, 
18.29, 14.13, 1.02. 
 
OmpF expression, extraction 
Both OmpF wild type and the OmpF-M double mutant (OmpF K89C/R270C) were expressed 
and purified following a published procedure.199 Protein purity was evaluated on a 12 % SDS-
PAGE gel, and the concentration measured spectrometrically at λ = 280 nm with Nanodrop 
(Witec Ag). Wild type and mutant OmpF were stored at 4 °C in 3 % OG at a concentration of 
around 3 mg/mL for several months. Before the reconstitution experiments, OmpF was dialysed 
against 1 L of 0.05 % OG in PBS for 16 h, then 2x against PBS for 2 h. After the dialysis, the 
protein concentration was adjusted to 2.0 mg/mL in PBS. 
 
Chemical modification of protein gate OmpF double mutant (OmpF-M) 
OmpF-M was diluted with PBS solution containing 3 % OG to a concentration of 1 mg/mL 
(500 µL, 25 mM, 12.5 nmol). Next, a solution of the linker in MilliQ-H2O (7.5 mM) was added 
(2.5 µL, 19 nmol). The mixture was stirred overnight in the dark at RT. The OmpF-M labelled 
with the linker (linker-OmpF-M) was washed 12 times with 1 % OG in PBS in Amicon Ultra-
0.5 mL centrifugal filters for protein purification and concentration, molecular cutoff 10 kDa 
(Millipore). The volume of linker-OmpF-M suspension was adjusted to 450 μL, transferred to 
a dialysis tubing with a 14 kDa molecular cutoff (Carl Roth), and dialyzed against 1 % OG 
solution in PBS, for 16 h, followed by 2x2 h dialysis against PBS. After dialysis, the protein 
concentration of linker-OmpF-M was measured spectrometrically at λ = 280 nm with Nanodrop 
(Witec Ag) and adjusted to 2.0 mg/mL.  
 
Characterization of linker-OmpF-M 
2.5-5 µL of OmpF WT, OmpF-M and linker-OmpF-M were each mixed with 4 x laemmli 
loading buffer (2.5 µL) containing mercaptoethanol (0.7 mM). The volume was adjusted to 
12.5 µL with 1 % OG solution and samples denatured at 95 °C for 5 min. Samples (10 µL) were 
loaded on a 4-20 % precast polyacrylamide gel (Mini-PROTEAN® TGX™) and ran at 200 V 
for 45 min (Figure S5). Before Coomassie staining, the gel was imaged by Bio-Rad GelDoc to 
observe the emitted fluorescence of the linker (fluorescence of cyanine3 maleimide: 550/580). 
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Preparation of bioactive polymersomes with encapsulated laccase 
5 mg PMOXA11-b-PDMS104-b-PMOXA11 triblock copolymer was dissolved in 186 µL EtOH. 
154 µL of dialyzed OmpF (2.0 mg/mL) or dialyzed OG solution (3 %) as control, were added. 
After evaporating the solvents by a rotary evaporator (155 rpm, 40 °C, 175 mbar for 10 min, 
then vacuum for 15 min), the polymer films were rehydrated with 1 mL laccase from Agaricus 
bisporus dissolved in PBS (4.6 µg/mL). For self-assembling nanocompartments, the mixture 
was stirred overnight at RT. After extrusion (200 nm polycarbonate filters), the 
nanocompartments were purified by size exclusion chromatography (SEC) and subsequently 
incubated with Proteinkinase K (1 mg/mL, 1-2 µL per 100 µL) to remove non-encapsulated 
enzyme. 
 
Characterization of CNCs with protein gates 
The size and morphology of polymersomes were evaluated by using a combination of light 
scattering (SLS, DLS), transmission electron microscopy (TEM) and fluorescence correlation 
spectroscopy (FCS). Quantification of reconstituted linker-OmpF-M was carried out by FCS 
measurements. With all three techniques, we were able to confirm the vesicular, hollow sphere 
structure of the CNCs with a size of around 200 nm. Additionally, we calculated the value for 
Rh by using the diffusion time of FCS measurements from the BODIPY stained vesicles (Table 
S1). With a diffusion time of around 6000 µs, we received a Rh of 92.1 nm resulting in a 
polymersome diameter of 184.2 nm, which is also in agreement with the results from TEM and 
LS (Figure 2). Cryo-TEM images of vesicles formed by the triblock copolymer PMOXA11-b-
PDMS104-b-PMOXA11 further showed a membrane thickness of around 15 nm (Figure S10).  
To exclude unspecific binding of linker-OmpF-M to the CNC membrane, FCS measurements 
were performed with linker-OmpF-M added to preformed, CNC-noOmpF (Figure S11, Table 
S1). Although FCS measurements revealed an increased diffusion time compared to the free 
linker, the shift of fitted autocorrelation curves was less pronounced than that observed for 
linker-OmpF-M reconstituted into CNCs. In addition, to confirm that the detergent (1 % OG) 
used to solubilize linker-OmpF-M did not disrupt CNCs, we added hydrophobic BODIPY 
630/650-X to stain the nanocompartment membrane and measure the vesicle diffusion time by 
FCS.  
 
DLS/SLS - Light scattering experiments were performed using an ALV goniometer (ALV 
GmbH, Germany) equipped with an ALV He−Ne laser (JDS Uniphase, wavelength λ = 
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632.8 nm). The solutions after film rehydration method (10 µL of suspended 
nanocompartments in 990 µL PBS) were measured in a 10 mm cylindrical quartz cell at angles 
ranging from 35° to 135° at 293 K with angular steps of 5°. ALV/Static and Dynamic FIT and 
PLOT program version 4.31 10/10 were used for data analysis. Static light scattering data were 
processed according to the MIE and Guinier plotting models. 
TEM Nanocompartments solutions were diluted in a ratio of 1:3 with PBS. 5 µL aliquots were 
deposited on a carbon-coated copper grid and negatively stained with 2 % uranyl acetate 
solution and deposited on a carbon-coated copper grid. The samples were examined with a 
transmission electron microscope (Philips CM-100) operated at 80 kV.  
Cryo-TEM - Aliquots of the samples (4 μL) were deposited on a holey carbon-coated grid 
(Lacey, Tedpella, USA), and vitrified into liquid ethane at -178 °C using a Leica GP plunger 
(Leica, Austria). The frozen samples were examined with a Talos electron microscope (FEI, 
USA) operated at 200 kV.  
NTA - NTA measurements were performed using a NanoSight NS3000 equipped with a blue 
(488 nm) and green laser (532 nm). The samples were diluted at 1:1000 in PBS to avoid 
interferences. The CNCs were excited with the blue laser and their emission was detected by 
using appropriate filters. The average particle concentration was calculated through the 
Stokes−Einstein equation related to a sphere, and their hydrodynamic radius distribution was 
analysed by NanoSight’s single particle tracking system. 
FCS - FCS measurements were carried out using a confocal laser scanning microscope (ZEISS 
ZEISS LSM 880, inverted microscope ZEISS Axio Observer, Carl Zeiss, Germany) equipped 
with a water immersion objective (C-Apochromate 40x/1.2W korr FCS M27) using the Zen 
Black software. A HeNe laser (561 nm or 633 nm) was used to excite the samples. The 
measurements were carried out at room temperature using a sample volume of 20 μL. 
Measurements were recorded over 10 s, and each measurement was repeated 30 times. The 
diffusion times of the free dye (100 nM cyanine3 maleimide), the linker and the different types 
of CNCs were measured independently. The autocorrelation function was calculated using a 
software correlator and fitted with a one component fit. Less than 10% of the correlation curves 
could not be fitted and were excluded from the analysis. Correlation curves that could not be 
fitted were excluded (<10%).  
For determining the specific binding of the linker to OmpF-M and the reconstitition of linker-
OmpF-M in the polymeric membrane, experimental auto correlation curves were fitted using a 
two-component model including the triplet state (Eq. 1). 
Eq. 1: 	
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(τ)fit = 1 + '1 +
𝑇































τD represents the diffusion time, T the fraction of fluorophores in triplet state with triplet time 
τtrip, N is the number of particles and R the structural parameter.  
R and τD of free dye (cyanine 3 maleimide) and the free linker were determined independently, 
experimental auto correlation curves were fitted using a one component model including triplet 
state (Eq. 2). 
Eq. 2: 
G(τ)fit = 1 + (1 +
𝑇















τD represents the diffusion time, T the fraction of fluorophores in triplet state with triplet time 
τtrip, N is the number of particles and R the structural parameter.  
Enzyme encapsulation efficiency  
The concentration of non-encapsulated laccase (laccase from Agaricus bisporus MW: 
65,000 g/mol238, confirmed by SDS PAGE, Figure S12) was determined from the 
fraction of laccase in solution eluted from size exclusion (SEC) purification of CNC-
noOmpF. Based on the BCA calibration curve (Figure S12) performed according to the 
supplier’s protocol (Thermo Fisher Scientific, U.S.A.), we determined the initial 
concentration of the laccase in solution (4.60 µg/mL) and subsequently quantified the 
amount of enzyme that was not encapsulated in the CNCs (total volume 0.85 mL, 
2.6x1011 ± 1.6x1010 vesicles/mL, measured by NTA; see Table S2). The difference 
between the amount of laccase added for the formation of the CNCs and the amount of 
enzyme that was not encapsulated (3.70 µg), corresponded to the amount of laccase 
encapsulated in our CNCs-noOmpF. Dividing the total number of encapsulated laccase 
molecules by the number of vesicles yielded a value of 8-9 encapsulated laccase 
molecules per vesicle. 
 
How to open linker-OmpF-M  
To 100 µL of CNCs without OmpF and CNCs with linker-OmpF-M inserted in their 
membrane, NaIO4 dissolved in MilliQ-H2O (0.3 M, 10 µL, 1 eq.) was added and 
incubated at 37° C for 24 h. An excess of glucose dihydrate dissolved in MilliQ-H2O 
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(0.6 M, 25 µL, 5 eq.) was added to quench NaIO4. We added approximately 2x1010 
CNCs to an aqueous solution of NaIO4 to a final periodate concentration of 30 mM in 
110 µL, corresponding to 1.6x10-7 mmol or 3.5 x10-5 mg periodate per vesicle. The 
mixture was incubated at 37° C for 24 h. Subsequently, CNCs were purified by SEC and 
incubated with proteinase K (1 mg/mL, 2 µL per 100 µL) to remove the free laccase. 
 
Enzymatic assay with DMP  
CNCs (5 µL) without NaIO4-treatment or CNCs incubated with NaIO4 and glucose (20 µL due 
to dilution after SEC purification) per well were added to 2,6-dimethoxyphenol (DMP) in PBS 
(20 mM, 10 µL) at pH 7.4 (total volume 210 µL) in a 96-well plate. The absorbance at 470 nm 
was measured with a Spectramax M5e microplate reader (Molecular Devices). The activity was 
measured for free laccase in solution (1 pg, corresponding to the amount of laccase in 1x109 
CNCs, 5 µL sample), for CNCs equipped with wild-type OmpF or double mutant OmpF-M, 
CNCs without inserted OmpF (before and after NaIO4-treatment) and CNCs with linker-OmpF-
M inserted in the membrane (before and after NaIO4-treatment). The concentration of all CNC 
samples in PBS solution was determined by NTA (Table S2) to perform the assays at 
comparable enzyme concentrations.  
 
Enzymatic assay with ABTS  
Corresponding laccase activity measurements were carried out using 2,2'-azinobis [3-
ethylbenzothiazoline-6-sulfonic acid]-diammonium salt (ABTS) as substrate. The oxidation 
product was monitored by determining the increase of absorbance at 420 nm using a 






All materials were purchased from Sigma Aldrich, except CellMaskTM Green Plasma 
Membrane Stain, GibcoTM Collagen I coated plate 6 well, FluoSpheresTM Carboxylate 
Mircospheres red fluorescent (580/605) 2-5 % solid (0.04 µm, 0.1 µm, 0.5 µm) were purchased 
from ThermoFisher. Red fluorescent polystyrene latex particles were purchased from 
Magsphere. Orange fluorescent (575/540) amine-modified polystyrene latex beads (0.1 µm, 
2.5 % solid) were purchased from Merck. 
 
Methods 
CellMask™ Green staining, solid-sphere particle uptake and packaging  
Cells were either cultured at a density of 5´104 cells per well in a µ-Slide 8 well, or at a density 
of 6´106 in a 6 well, in 200 µL or 500 µL cell medium respectively. The cells were grown as 
uniform monolayer with appropriate morphology and with at least 70% confluency.  In case of 
HepG2 and HeLa cells, the medium was DMEM growth medium (High Glucose Dulbecco’s 
Modified Eagle Medium (DMEM)), supplemented 10 % fetal calf serum, penicillin 
(100 units/mL) and streptomycin (100 µg/mL)). In case of Caco-2, the cell medium was Eagle's 
Minimum Essential Medium (EMEM) supplemented with 1X NEAA (non-essential amino 
acids), 2 mM glutamine, 10 % fetal calf serum, penicillin (100 units/mL) and streptomycin 
(100 µg/mL).  After incubation for 24 h at 37 ºC, 5% CO2 the medium was removed and 200 µL 
or 500 µL of FluoSpheres™ Carboxylate-Modified Microspheres, 2 % solids diluted to 4´109 
particles/mL, 8´109 particles/mL, 1.6´1010 particles/mL, and 1.6´1011 particles/mL in 
DMEM/EMEM growth medium were added to the cells. Cells were incubated for an additional 
24 h in DMEM/EMEM growth medium, then washed five times with 200 µL (8 well chambers) 
or 3 mL (6 well) DMEM/EMEM growth medium. After the final wash step, the DMEM/EMEM 
growth medium was removed and CellMask™ Green diluted 1:1000 in DMEM/EMEM growth 
medium was added. After incubation for 10 min the medium was removed, and the cells were 
washed 3 times with 200 µL (8 well chambers) or 3 mL (6 well chambers) cell medium. Then 
vesiculation buffer (1 mL solution of 10mM HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid), 150 mM NaCl, 2 mM CaCl2, pH 7.4, 18 µL of 4 % (wt/vol) 
PFA solution, 2 µL of 1 M DTT) was added (200 µL for 8 well chambers, or 500 µL for 6 well 




Cells were plated as described above in 8 or 6 well plates. 1 min after culturing the cells, 10 µL 
of CellLight® Plasma Membrane-GFP BacMam 2.0 was added for cells cultured in the 8 wells 
plates and 25 µL for cells cultured in 6 well plates. Subsequently, cells were incubated for 24 h 
at 37 ºC, and 5 % CO2 to allow attachment to the surface. 
 
Isolation of GPMVs 
The supernatant (500 µL) from 6 well cell culture plates was transferred to an Eppendorf tube 
and centrifuged at 0.1 rpm for 10 min to pellet and remove cells. The supernatant containing 
the GPMVs was transferred to plasma activated 2 well microscopy chambers (NuncTM Lab-
TekTM Chamber Slide System, Thermo Fisher Scientific). 
 
CLSM 
CLSM measurements were performed using a confocal laser scanning microscope (ZEISS LSM 
880, inverted microscope ZEISS Axio Observer, Carl Zeiss, Germany) equipped with a water 
immersion objective (C-Apochromate 40x/1.2W korr FCS M27) using the Zen Black software. 
Samples containing CellMaskTM Green Plasma Membrane Stain, GFP or the aminated NPs 
were excited with an argon laser at 488 nm by setting the detector range to 499-521 nm. To 
measure the fluorescence of FluospheresTM Carboxylate Mircospheres, a diode-pumped solid-
state 561-10 laser (DPSS) at 561 nm was used as excitation source and the detector range set to 
572-704 nm. Respectively, nanocompartment beam splitters (MBS) of 488 and 561 were used. 
Each sample was scanned unidirectionally using 1024´1024 pixels with a Bit Depth of 16 Bit. 
Images were processed using ImageJ software.  
 
Flow cytometry analysis of GPMVs 
The cells were grown in 6 well plates as described above and the GPMVs were subsequently 
isolated as described above for CLSM studies. Flow cytometry analysis was performed using a 
BD LSR Fortessa Analyzer. Doublets were excluded using FSC-A and FSC-H detectors. The 
GPMVs were excited at 541 nm, and the emission was detected using the Texas-Red Channel 
(BP filter 620/10). 100 000 events were recorded for each sample in “slow” flow through mode. 





Flow cytometry analysis of cells 
For cellular uptake studies cells were grown and incubated with NPs in 6 wells as described 
above. Cells were washed five times with cell medium, trypsinized, resuspended in 1 mL cell 
medium, centrifuged and then suspended in 500 µL PBS. Flow cytometry analysis was 
performed using a BD FACS Canto II flow cytometer (BD Bioscience, USA). Doublets were 
excluded using FSC and SSC detectors, single cells were excited at 561 nm and the emission 
was detected in FL5 (610/20; Texas-Red Channel). A total of 10,000 single cells for each 
sample were analyzed and data processed using Flow Jo VX software (TreeStar, Ashland, OR). 
 
NTA 
NTA measurements were performed using a NanoSight NS3000 equipped with a blue (488 nm) 
and red laser (642 nm). The NPs were excited with red laser and their emission was detected 
by using appropriate filter for 642 nm. The average particle concentration was calculated 
through the Stokes-Einstein equation related to a sphere and their hydrodynamic radius 
distribution was analyzed by NanoSight’s single particle tracking system 
 
TEM 
A suspension of 100 nm beads (1´109 particles/mL) in cell medium was used for TEM imaging 
studies. These samples were negatively stained with 1.5 % uranyl acetate solution and deposited 
on carbon-coated copper grids. A transmission electron microscope (Philips Morgagni 268D) 
at 293 K was used. 
 
DLS 
The measurements of hydrodynamic diameter (Rh) of NPs were performed on a Zetasizer Nano 
ZSP at 25 °C. The measure angle is 173 ° and the data was analyzed by intensity distribution. 












Figure S1. 1H-NMR spectrum of Compound 2 in CDCl3 at 500 MHz. 








Figure S4. 13C-NMR spectrum of the bismaleimide linker in CDCl3 at 126 MHz and the image 




Figure S5. SDS PAGE of OmpF-M (left, fluorogram, right, Coomassie-stained): L: Protein 
ladder; 1,2: unlabelled OmpF-M, at 1/1 (1) and 2/1 (2) ratio (v/v) with loading buffer. 3, 4: 
OmpF-M labelled with the linker comprising fluorescent cyanine 3 (550/580). MW of OmpF 
around 40 kDa. 
Table S1. Fluorescence correlation parameters of the free fluorophore cyanine3 maleimide, 
free linker, CNCs with OmpF-M-linker inserted in the membrane, stand-alone OmpF-M-linker, 
and OmpF-M-linker added to empty polymersomes before and after staining the polymersomes 







Cyanine3 maleimide 1.7 61 
Linker 2.3 70 
OmpF-M-Linker vesicles  28.3 4530 
Linker-OmpF-M 3.1 452 
Vesicles ANDlinker- 
OmpF-M without BODIPY 7.0 452 
Vesicles AND linker-





Figure S6. 1H-NMR spectrum of poly(2-methyl-2-oxazoline)-b-poly(dimethylsiloxane)-b-
poly(2-methyl-2-oxazoline) triblock copolymer (PMOXA11-b-PDMS104-b-PMOXA11) in CDCl3 
at 500 MHz. 
Figure S7. Elugram (GPC) of PMOXA11-b-PDMS104-b-PMOXA11 in DMF. 
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Table S2.  Data from NTA measurements of CNC-noOmpF, CNC-linker-OmpF-M, CNC-
OmpF-M), and CNC-OmpF-WT samples diluted 1:1000 in PBS. 
 CNC-noOmpF CNC-linker-OmpF-M CNC-OmpF-M CNC-OmpF-WT 











Figure S8. Laccase activity of CNCs in response to NaIO4 (with standard deviation). 
Measurements were carried out over 9 h at RT, pH 7.4: ABTS in PBS with CNC-OmpF-WT 
(black), ABTS in PBS with CNC-OmpF-M (red), ABTS in PBS CNC-linker-OmpF-M in the 
presence (green) and absence of NaIO4 (blue), CNC-noOmpF without (purple) and with NaIO4 




Figure S9. TEM micrographs of different CNCs encapsulating laccase 11 month after 
preparation. Left, with linker-OmpF-M inserted in the membrane (CNC-linker-OmpF-M), 
middle, with inserted OmpF-M (CNC-OmpF-M), right, with inserted wild-type OmpF (CNC-
OmpF-WT). Scalebars: 500 nm 
 
Figure S10. Cryo-TEM micrographs of polymersomes self-assembled from PMOXA11-b-




Figure S11. FCS curves (line) and raw data (dots) of PBS solutions of cyanine 3 maleimide 
(pink), OmpF-M-linker in 1% OG mixed with empty polymersomes before (blue), and after 
stained with BODIPY 630/650-X (red). 





Figure S13. Calibartion curve for BCA assay performed according to the supplier’s protocol 

























 Original concentration of 
suspension (particles/mL) 
FluoSpheresTM  40 nm 1 ´ 1013 
FluoSpheresTM  100 nm 8 ´ 1012 
FluoSpheresTM  500 nm 2 ´ 1011 
amine-modified PS NPs 100 nm 2 ´ 1011 
red-fluorescent PS NPs 100 nm 8 ´ 1012 
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Figure S14. Formation of GPMVs from HepG2, Caco-2 and HeLa cells after incubation with 
100 nm fluorescent aminated NPs (yellow) or unmodified NPs (red) with initial concentrations 
between 4´109 particles/mL and 1.6´1011 particles/mL. 
 
 92 
Figure S15. GPMVs formed from HepG2, HeLa and Caco-2 cells with transferred, red 
fluorescent carboxylated NPs inside their cavities. The NPs are of 40 nm or 100 nm size with 







Figure S16. GPMVs formed from HepG2, Caco-2 and HeLa cell lines treated with red 
fluorescent carboxylated NPs (500 nm with initial concentrations between 4´109 particles/mL 






Figure S17. Flow cytometry analysis of HepG2 cells with uptaken NPs: A) cellular uptake 
depending on the concentration of 40 nm red fluorescent carboxylated PS NPs. REF no NPs 
(grey), 1: 4´109 particles/mL (blue), 2: 8´109 particles/mL (green), 3: 1.6´1010 particles/mL 
(red). B) flow cytometry analysis of HepG2 cell size characterization by sideward (SSC) and 
forward scattering (FSC) analysis. The marked-out section represents the cell populations used 
for further NP uptake analysis by flow cytometry by PE-Texas Red A. C) cellular uptake 
depending on the concentration of 100 nm red fluorescent carboxylated PS NPs. REF no NPs 
(grey), 1: 4´109 particles/mL (blue), 2: 8´109 particles/mL (green), 3: 1.6´1010 particles/mL 
(red). D) flow cytometry analysis 100 nm NPs, size characterization by sideward and forward 
scattering analysis. The marked-out section represents the cell populations used for analysis 
by flow cytometry.  
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Figure S18. Flow cytometry analysis of Caco-2 cells with uptaken NPs: A) cellular uptake 
depending on the concentration of 40 nm red fluorescent carboxylated PS NPs. REF no NPs 
(grey), 1: 4´109 particles/mL (blue), 2: 8´109 particles/mL (green), 3: 1.6´1010 particles/mL 
(red). B) flow cytometry analysis of Caco-2 cell size characterization by sideward (SSC) and 
forward scattering (FSC) analysis. The marked-out section represents the cell populations used 
for further NP uptake analysis by flow cytometry by PE-Texas Red A. C) cellular uptake 
depending on the concentration of 100 nm red fluorescent carboxylated PS NPs. REF no NPs 
(grey), 1: 4´109 particles/mL (blue), 2: 8´109 particles/mL (green), 3: 1.6´1010 particles/mL 
(red). D) flow cytometry analysis 100 nm NPs, size characterization by sideward and forward 
scattering analysis. The marked-out section represents the cell populations used for analysis 




Figure S19. Flow cytometry analysis of HeLa cells with uptaken NPs: A) cellular uptake 
depending on the concentration of 40 nm red fluorescent carboxylated PS NPs. REF no NPs 
(grey), 1: 4´109 particles/mL (blue), 2: 8´109 particles/mL (green), 3: 1.6´1010 particles/mL 
(red). B) flow cytometry analysis of HeLa cell size characterization by sideward (SSC) and 
forward scattering (FSC) analysis. The marked-out section represents the cell populations used 
for further NP uptake analysis by flow cytometry by PE-Texas Red A. C) cellular uptake 
depending on the concentration of 100 nm red fluorescent carboxylated PS NPs. REF no NPs 
(grey), 1: 4´109 particles/mL (blue), 2: 8´109 particles/mL (green), 3: 1.6´1010 particles/mL 
(red). D) flow cytometry analysis 100 nm NPs, size characterization by sideward and forward 
scattering analysis. The marked-out section represents the cell populations used for analysis 




Figure S20. Relative fluorescence (RFU) of flow cytometry analysis given in Figure S6-S8: 
HepG2, Caco-2 and HeLa cells without NPs and treated with 40 nm (yellow) and 100 nm 
(green) PS NPs at 3 different concentrations (4´109 particles/mL, 8´109 particles/mL (green), 
1.6´1010 particles/mL). Error bars are given as ± standard deviation, significance level: p < 
0.5 (*). 
Figure S21. Evaluation of single plane projections of GPMVs formed from HepG2 cells treated 
with 40 nm carboxylated NPs at different concentrations: A) 4´109 particles/mL, B) 8´109 
particles/mL, C) 1.6´1010 particles/mL, D) 1.6´1011 particles/mL. 
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Figure S22. Evaluation of single plane projections of GPMVs formed from HepG2 cells treated 
with 100 nm carboxylated NPs at different concentrations: A) 4´109 particles/mL, B) 8´109 
particles/mL, C) 1.6´1010 particles/mL, D) 1.6´1011 particles/mL. 
 
Figure S23. Evaluation of single plane projections of GPMVs formed from Caco-2 cells treated 
with 40 nm carboxylated NPs at different concentrations: A) 4´109 particles/mL, B) 8´109 
particles/mL, C) 1.6´1010 particles/mL, D) 1.6´1011 particles/mL. 
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Figure S24. Evaluation of single plane projections of GPMVs formed from Caco-2 cells treated 
with 100 nm carboxylated NPs at different concentrations: A) 4´109 particles/mL, B) 8´109 
particles/mL, C) 1.6´1010 particles/mL, D) 1.6´1011 particles/mL. 
 
Figure S25. Evaluation of single plane projections of GPMVs formed from HeLa cells treated 
with 40 nm carboxylated NPs at different concentrations: A) 4´109 particles/mL, B) 8´109 
particles/mL, C) 1.6´1010 particles/mL, D) 1.6´1011 particles/mL. 
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Figure S26. Evaluation of single plane projections of GPMVs formed from HeLa cells treated 
with 100 nm carboxylated NPs at different concentrations: A) 4´109 particles/mL, B) 8´109 




Figure S27. GPMVs formed from HepG2, Caco-2 and HeLa cell lines treated with 40 nm red 
fluorescent carboxylated NPs. From left to right the initial concentrations are 4´109 
particles/mL, 8´109 particles/mL, 1.6´1010 particles/mL and 1.6´1011 particles/mL. After 
formation the GPMVs were isolated. 
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Figure S28. GPMVs formed from HepG2, Caco-2 and HeLa cell lines treated with 100 nm red 
fluorescent carboxylated NPs. From left to right the initial concentrations are 4´109 
particles/mL, 8´109 particles/mL, 1.6´1010 particles/mL and 1.6´1011 particles/mL. After 
formation the GPMVs were isolated. 
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SRB  sulphorhodamine B  
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